Data / Research funding / Coronaviruses
Coronaviruses: 2,011 NIH awards ($6.1B) to 518 organizations
2,011 NIH awards ($6.1B) in the NIH spending category Coronaviruses, to 518 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 2,011 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| ACTIV Integration of Host-targeting Therapies for COVID-19 Administrative Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $965,792,899 | June 15, 2020 | June 30, 2026 | THOMAS, SONIA M | reporter.nih.gov |
| OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository Core | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $650,978,035 | May 24, 2021 | May 23, 2025 | KATZ, STUART D | reporter.nih.gov |
| Interactive Data Portals and Robust Analytic Tools to Wrap PASC Cohorts (iDRAW) OTA-21-015A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $182,207,494 | June 10, 2021 | June 9, 2024 | FOULKES, ANDREA S | reporter.nih.gov |
| CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $156,469,927 | March 30, 2022 | March 31, 2022 | COREY, LAWRENCE | reporter.nih.gov |
| Health and Retirement Study: Yrs 35-40 | NIH | National Institute on Aging | 2021 to 2025 | $142,220,153 | September 25, 1990 | December 31, 2029 | WEIR, DAVID R. | reporter.nih.gov |
| RADx-UP CDCC | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $96,490,468 | September 27, 2020 | June 30, 2025 | COHEN-WOLKOWIEZ, MICHAEL | reporter.nih.gov |
| AI-driven Structure-enabled Antiviral Platform (ASAP) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $89,845,851 | May 16, 2022 | August 31, 2027 | CHODERA, JOHN DAMON | reporter.nih.gov |
| CLINICAL RESEARCH OPERATIONS AND MANAGEMENT SUPPORT (CROMS) - SARS CoV-2 Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $86,825,316 | April 17, 2017 | April 16, 2024 | HOLMES, MELYNDA | reporter.nih.gov |
| COVID-19: NIAID Regulatory Support Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $63,227,516 | April 15, 2023 | April 14, 2024 | RAFI, ASIMAH | reporter.nih.gov |
| CoVPN 5001 - A prospective study of acute immune responses to SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $57,987,348 | March 21, 2022 | March 31, 2022 | GILBERT, PETER B. | reporter.nih.gov |
| HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $54,331,950 | March 18, 2022 | March 31, 2022 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| Regulation of B cell Responses in SLE and Other Autoimmune Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $53,786,694 | May 1, 2014 | April 30, 2029 | SANZ, IGNACIO E. | reporter.nih.gov |
| Tulane National Primate Research Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $52,341,995 | May 9, 1997 | April 30, 2028 | HAMM, L LEE | reporter.nih.gov |
| West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $31,832,071 | August 15, 2012 | June 30, 2027 | HODDER, SALLY LYNN | reporter.nih.gov |
| SECURE PLATFORMS SUPPORT FOR THE N3C DATA ENCLAVE (COVID-19) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $30,357,494 | August 2, 2023 | September 24, 2023 | MARIZAN-HO, JOHANNA | reporter.nih.gov |
| COPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 3 - AUGUST 10, 2025 - AUGUST 9, 2026 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $29,553,568 | August 10, 2025 | August 9, 2026 | NEWMAN, LEE S | reporter.nih.gov |
| RADX-TECH - LUMINOSTICS, INC. SMARTPHONE-BASED TEST FOR RAPID SARS-COV-2 ANTIGEN DETECTION FROM NASAL SWABS | NIH | National Heart, Lung, and Blood Institute | 2021 | $28,624,460 | September 30, 2020 | September 29, 2021 | RAJA, BALA | reporter.nih.gov |
| STSS: SMART IRB ONLINE RELIANCE SYSTEM (ORS) AND JOINDER ENHANCEMENTS SUPPORT SERVICES | NIH | National Institute on Drug Abuse | 2021 to 2022 | $27,880,093 | April 15, 2022 | April 14, 2023 | MAYS, GARY | reporter.nih.gov |
| Northern New England Clinical and Translational Research Network | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $27,379,043 | July 3, 2017 | June 30, 2027 | ROSEN, CLIFFORD JAMES | reporter.nih.gov |
| Louisiana Clinical and Translational Science Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $25,457,946 | August 15, 2012 | June 30, 2027 | KIRWAN, JOHN P. | reporter.nih.gov |
| Oklahoma Shared Clinical and Translational Resources | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $24,697,580 | September 1, 2013 | June 30, 2028 | JAMES, JUDITH A | reporter.nih.gov |
| TASK ORDER 7 - ODP | NIH | National Institute on Drug Abuse | 2024 | $23,970,498 | May 31, 2024 | September 30, 2024 | MAYS, GARY | reporter.nih.gov |
| Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations | NIH | National Institute on Aging | 2023 to 2025 | $23,106,653 | August 15, 2023 | July 31, 2028 | DE ERAUSQUIN, GABRIEL ALEJANDRO | reporter.nih.gov |
| New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,744,885 | September 30, 2001 | March 31, 2029 | LUSETTI, SHELLEY | reporter.nih.gov |
| COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $20,632,183 | September 30, 2023 | September 29, 2024 | DENNY, THOMAS | reporter.nih.gov |
| BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $20,255,157 | September 15, 2019 | September 14, 2024 | STEVENS, RICK | reporter.nih.gov |
| MT INBRE: A Multidisciplinary Research Network | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,222,717 | September 25, 2001 | April 30, 2029 | BOTHNER, BRIAN P | reporter.nih.gov |
| ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $18,205,751 | September 19, 2022 | September 18, 2026 | SAUNDERS, KEVIN | reporter.nih.gov |
| Alzheimer's Disease Research Center | NIH | National Institute on Aging | 2021 to 2025 | $17,255,961 | June 15, 2020 | April 30, 2030 | SMALL, SCOTT A | reporter.nih.gov |
| East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,134,028 | June 1, 2025 | June 30, 2026 | WOOLS-KALOUSTIAN, KARA KAY | reporter.nih.gov |
| International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,840,939 | May 1, 2025 | April 30, 2027 | ROHNER, ELIANE | reporter.nih.gov |
| Center for Viral Systems Biology (CViSB) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,438,330 | February 1, 2018 | January 31, 2028 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| The NYU Children’s Health & Environment Study: an ECHO Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $16,199,294 | September 21, 2016 | May 31, 2025 | TRASANDE, LEONARDO | reporter.nih.gov |
| DEVELOPMENT OF A VACCINE CANDIDATE FOR CORONAVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $15,898,493 | June 1, 2023 | May 31, 2026 | KRAMMER, FLORIAN | reporter.nih.gov |
| EXERCISE OPTION PERIOD 1 TO PROVIDE SUPPORT FOR TECHNICAL ASSESSMENTS AND PROJECT MANAGEMENT FOR THE NIBIB RAPID ACCELERATION OF DIAGNOSTICS (RADX) IN | NIH | National Heart, Lung, and Blood Institute | 2021 | $14,996,149 | April 15, 2021 | October 14, 2021 | MARINO, MARK | reporter.nih.gov |
| Anti-NMDA Receptor Antibodies in Adult Brain Dysfunction: Lessons from Lupus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,990,990 | August 1, 2008 | June 30, 2030 | DIAMOND, BETTY | reporter.nih.gov |
| HIPC Data Coordinating Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $14,760,228 | April 13, 2022 | March 31, 2027 | PETERS, BJOERN | reporter.nih.gov |
| CODA: COvid and Diabetes Assessment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $14,508,027 | July 21, 2023 | June 30, 2028 | ROTHMAN, RUSSELL L. | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| Center for Cancer Immunology and Immunotherapy (CCII) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $14,096,415 | February 1, 2020 | May 31, 2030 | YAN, JUN | reporter.nih.gov |
| Caribbean Primate Research Center Program | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $14,084,108 | April 15, 1987 | November 30, 2028 | LOPEZ, MARCOS | reporter.nih.gov |
| Center for Translational Pediatric Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $14,029,666 | July 11, 2017 | June 30, 2027 | TACKETT, ALAN | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO ADD MILESTONE 1A, REVISE THE DELIVERABLES FOR MILESTONE 4-10, AND REVISE THE BASE POP TO END ON 1/18/2022. | NIH | National Heart, Lung, and Blood Institute | 2021 | $13,419,752 | June 8, 2021 | December 21, 2021 | MARINO, MARK | reporter.nih.gov |
| Trusted Training: Improving Health and Safety Through an All-Hazard Training Approach | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $13,355,376 | September 1, 1992 | May 31, 2030 | FITCH, ASHLEE | reporter.nih.gov |
| University of New Mexico Center for Metals in Biology and Medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,321,441 | July 1, 2020 | April 30, 2030 | CAMPEN, MATTHEW J | reporter.nih.gov |
| Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,884,300 | September 1, 2003 | April 30, 2029 | DAVIS, MARK MORRIS | reporter.nih.gov |
| HEALTH Center for Addictions Research and Cancer Prevention | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $12,882,144 | September 8, 2020 | April 30, 2026 | BEECH, BETTINA M. | reporter.nih.gov |
| Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,773,513 | January 17, 2018 | December 31, 2027 | WUNDERINK, RICHARD G | reporter.nih.gov |
| RADXHIV VIRAL LOAD | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $12,723,739 | September 11, 2007 | July 31, 2028 | MANABE, YUKARI C | reporter.nih.gov |
| Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,580,221 | June 1, 2025 | May 31, 2027 | SETTE, ALESSANDRO | reporter.nih.gov |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects | NIH | National Institute on Aging | 2021 to 2022 | $12,573,346 | May 1, 2019 | February 28, 2023 | DIDSBURY, JOHN | reporter.nih.gov |
| Development of an Antiviral to Combat Viral Infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $12,480,276 | November 15, 2022 | April 17, 2025 | CHANG, JINHONG | reporter.nih.gov |
| RAPID ACCELERATION OF DIAGNOTICS (RADX) ADVANCED TECHNOLOGIES PLATFORM RAPID ACCELERATION OF DIAGNOTICS (RADX) ADVANCED TECHNOLOGIES PLATFORM PROJECT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $12,461,593 | July 30, 2020 | April 15, 2022 | LU, JAMES | reporter.nih.gov |
| Trans-omics Integration of Multi-omics Studies for Osteoporosis | NIH | National Institute on Aging | 2021 to 2025 | $12,202,183 | September 15, 2017 | June 30, 2027 | DENG, HONG-WEN | reporter.nih.gov |
| Tissue and organ specific human B cell immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $12,146,380 | April 1, 2019 | March 31, 2025 | LUND, FRANCES E. | reporter.nih.gov |
| NATIONAL CLINICAL DATA COLLABORATIVE COUNTS (NACDACC) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $12,127,951 | September 30, 2024 | September 29, 2025 | MAYS, GARY | reporter.nih.gov |
| Center for Redox Biology and Cardiovascular Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,065,347 | February 1, 2018 | June 30, 2028 | KEVIL, CHRISTOPHER G | reporter.nih.gov |
| Human anti-viral immune responses in tissues and circulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,930,741 | January 1, 2017 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| Alzheimer's Disease and Related Disorders Treatment and Outcomes in America: Changing Policies and Systems. | NIH | National Institute on Aging | 2021 to 2025 | $11,898,685 | September 15, 2007 | May 31, 2029 | TRIVEDI, AMAL N. | reporter.nih.gov |
| RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization | NIH | National Library of Medicine | 2021 to 2022 | $11,803,325 | December 21, 2020 | November 30, 2022 | OHNO-MACHADO, LUCILA | reporter.nih.gov |
| Durable Alteration of the Human Immune system after Infection or Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,785,761 | June 8, 2009 | May 31, 2029 | CHUNG, RAYMOND T | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| COBRE Center on Opioids and Overdose | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,768,169 | September 1, 2018 | August 31, 2028 | RICH, JOSIAH D | reporter.nih.gov |
| Racial Differences in Late-Life Cognitive decline and risk of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $11,402,108 | September 30, 2004 | May 31, 2027 | BARNES, LISA L | reporter.nih.gov |
| West African Emerging Infectious Disease Research Center (WA-EIDRC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,322,650 | May 21, 2020 | June 5, 2025 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| Transition from Preschool through High School: Family, Schools & Neighborhoods | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $11,319,841 | July 3, 2007 | June 30, 2028 | ZHAO, WEI | reporter.nih.gov |
| Clinical Development of COVID-19 Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $11,286,393 | September 22, 2023 | February 15, 2026 | WANG, STANLEY | reporter.nih.gov |
| NYR-Diabetes Research Center (NYR-DRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,878,379 | December 1, 1996 | April 30, 2030 | PESSIN, JEFFREY E. | reporter.nih.gov |
| Administrative Supplement Request for 2025 Systems Biology for Infectious Diseases Annual Meeting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,511,156 | August 17, 2018 | May 31, 2028 | KROGAN, NEVAN J | reporter.nih.gov |
| Establish a Public Private Partnership for COVID19 Research | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $10,186,691 | May 2, 2020 | February 29, 2024 | ADAM, STACEY | reporter.nih.gov |
| Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,862,919 | March 22, 2022 | February 28, 2027 | FERNANDEZ-SESMA, ANA | reporter.nih.gov |
| NCATS SECURE SCIENTIFIC PLATFORMS ENVIRONMENT SUPPORT FOR THE N3C DATA ENCLAVE, POP 12/25/2020 - 9/27/2021 | NIH | National Institute on Drug Abuse | 2021 | $9,554,920 | December 25, 2020 | September 27, 2021 | ZAVERTNICK, BRIAN | reporter.nih.gov |
| Environmental Approaches to Prevention | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $9,318,439 | September 29, 1983 | November 30, 2027 | PASCHALL, MALLIE J | reporter.nih.gov |
| The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19 | NIH | National Institute on Aging | 2022 to 2024 | $9,143,854 | June 15, 2022 | May 31, 2026 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $8,902,713 | September 21, 2016 | May 31, 2025 | MACKENZIE, DEBRA | reporter.nih.gov |
| Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,860,022 | September 21, 2016 | May 31, 2030 | MACKENZIE, DEBRA | reporter.nih.gov |
| Task V34: Master Cell Banks Manufacturing for Next Generation SARS-CoV-2 Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $8,647,922 | May 15, 2018 | May 14, 2028 | TRUSHEIM, HEIDI | reporter.nih.gov |
| RADX PROGRAM: TECH PROJECT NO 6114 FLUIDIGM ADVANTA DX SARS-COV-2 RT-PCR ASSAY FOR SALIVA | NIH | National Heart, Lung, and Blood Institute | 2021 | $8,580,056 | July 30, 2020 | September 30, 2021 | QUONG, ANDREW | reporter.nih.gov |
| NCATS SCIENTIFIC AND TECHNOLOGY SUPPORT SERVICES (STSS) | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,491,687 | September 30, 2024 | January 6, 2025 | MAYS, GARY | reporter.nih.gov |
| Center for American Indian and Rural Health Equity | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $8,200,764 | September 15, 2014 | August 31, 2025 | ADAMS, ALEXANDRA K. | reporter.nih.gov |
| Human Biomimetics for Mucosal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,059,968 | March 15, 2015 | May 31, 2027 | ESTES, MARY KOLB | reporter.nih.gov |
| LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center (CARC) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,052,951 | December 1, 1996 | August 31, 2030 | MOLINA, PATRICIA E. | reporter.nih.gov |
| Integrating innate and adaptive pathways in vaccine responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $7,762,589 | April 1, 2014 | March 31, 2024 | RAVETCH, JEFFREY VICTOR | reporter.nih.gov |
| SUPPLEMENTAL FUNDS TO PROVIDE RADX INFRASTRUCTURE SUPPORT THROUGH JULY 1, 2021 | NIH | National Heart, Lung, and Blood Institute | 2021 | $7,499,311 | July 2, 2020 | April 30, 2021 | MARINO, MARK | reporter.nih.gov |
| Interactions Between the Microbiome, Immunity and Respiratory Health in Traditional Agrarian and Suburban children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,471,626 | February 1, 2013 | February 29, 2028 | GERN, JAMES E. | reporter.nih.gov |
| Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $7,369,853 | September 23, 2021 | February 28, 2025 | ALEM, FARHANG | reporter.nih.gov |
| RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT NO 2375 - MASSIVELY PARALLEL CENTRALIZED AND DECENTRALIZED ULTRAFAST COVID-19INFECTIOUS | NIH | National Heart, Lung, and Blood Institute | 2021 | $7,200,049 | September 30, 2020 | September 29, 2021 | BEEBE, DAVID | reporter.nih.gov |
| Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,143,498 | September 30, 2023 | September 29, 2028 | SORENSON, GREGORY | reporter.nih.gov |
| ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,937,118 | September 30, 2023 | September 29, 2026 | COLLINS, NICOLAS | reporter.nih.gov |
| Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,892,629 | September 15, 2004 | August 31, 2025 | FARRIS, A DARISE | reporter.nih.gov |
| The Mutant Mouse Resource and Research Center at The Jackson Laboratory | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $6,802,936 | January 1, 2010 | January 31, 2030 | LUTZ, CATHLEEN M | reporter.nih.gov |
| Emerging Infectious Diseases Research Center - East and Central Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,734,930 | June 1, 2020 | June 5, 2025 | NJENGA, M KARIUKI | reporter.nih.gov |
| Development of a COVID-19 Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,733,518 | September 1, 2020 | October 31, 2023 | REED, STEVEN | reporter.nih.gov |
| TNPRC Regional Biocontainment Laboratory Upgrade for Capacity Building | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,714,363 | September 23, 2021 | February 28, 2025 | RAPPAPORT, JAY | reporter.nih.gov |
| Emerging infections: surveillance, epidemiology and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,690,286 | May 11, 2020 | June 5, 2025 | WANG, DAVID | reporter.nih.gov |
| West African Center for Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,658,566 | June 9, 2020 | June 5, 2025 | WEAVER, SCOTT C | reporter.nih.gov |
| TO MODIFY THE CONTRACT AND ADD ADDITIONAL FUNDING TO CONFIGURE A SMARTPHONE AND WEB-BASED DIGITAL HEALTH SOLUTION TO SUPPORT THE GENERAL PUBLIC USE OF | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $6,630,083 | June 8, 2020 | June 7, 2022 | KHETERPAL, VIK | reporter.nih.gov |
| Role of Data Streams In Informing Infection Dynamics in Africa- INFORM Africa | NIH | Fogarty International Center | 2021 to 2025 | $6,610,435 | September 15, 2021 | June 30, 2027 | ABIMIKU, ALASH'LE G. | reporter.nih.gov |
| Facility and Building System Upgrades Support for the Howard T. Ricketts Biocontainment Laboratory | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,593,067 | September 16, 2021 | February 28, 2025 | ADAMS, ERIN JUNE | reporter.nih.gov |
| Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,550,363 | May 23, 2022 | September 30, 2026 | GRAHAM, RACHEL | reporter.nih.gov |
| Regional Biocontainment Laboratory (RBL) Upgrade for Colorado State University (CSU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,493,184 | September 23, 2021 | February 28, 2025 | DOBOS, KAREN MARIE | reporter.nih.gov |
| Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL | NIH | National Institute on Aging | 2022 to 2025 | $6,381,039 | September 1, 2022 | May 31, 2027 | HAINES, JONATHAN L | reporter.nih.gov |
| The PreVAIL-kIds Common Protocol | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $6,271,251 | January 1, 2021 | November 30, 2025 | ANNAPRAGADA, ANANTH V | reporter.nih.gov |
| 1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,197,105 | September 26, 2019 | August 31, 2025 | BAKER, VALERIE LYNN | reporter.nih.gov |
| TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,022,974 | September 30, 2019 | April 30, 2026 | CARSON, DENNIS | reporter.nih.gov |
| Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,015,134 | September 17, 2021 | August 31, 2025 | DEB, ARJUN | reporter.nih.gov |
| Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,841,904 | September 30, 2019 | April 30, 2026 | ESSER-KAHN, AARON | reporter.nih.gov |
| Improvements to the Regional Biocontainment Research Facilities at the University of Missouri | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $5,667,997 | September 23, 2021 | February 28, 2025 | LORSON, CHRISTIAN L. | reporter.nih.gov |
| NBER Center for Aging and Health Research | NIH | National Institute on Aging | 2021 to 2025 | $5,663,258 | August 1, 1997 | August 31, 2027 | CUTLER, DAVID M | reporter.nih.gov |
| CCC for NHLBI Prevention and Early Treatment of Acute Lung Injury PETAL Network | NIH | National Heart, Lung, and Blood Institute | 2021 | $5,617,232 | June 17, 2014 | October 31, 2023 | THOMPSON, BOYD TAYLOR | reporter.nih.gov |
| UAW Hazardous Material Worker Health and Safety Training (U45) | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $5,542,216 | September 1, 1992 | May 31, 2025 | SIVIN, DARIUS D | reporter.nih.gov |
| Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 Infection | NIH | National Institute on Aging | 2022 to 2025 | $5,518,240 | June 15, 2022 | March 31, 2027 | WISNIEWSKI, THOMAS M | reporter.nih.gov |
| Implementation of a Pragmatic Trial of Whole Health Team vs. Primary Care Group Education to Promote Non-Pharmacological Strategies to Improve Pain, Function and Quality of Life in Veterans | NIH | National Center for Complementary & Integrative Health | 2021 to 2024 | $5,266,106 | January 1, 2024 | December 31, 2025 | SEAL, KAREN H | reporter.nih.gov |
| Determinants of Elderly Health: The Role of Place-Based Factors | NIH | National Institute on Aging | 2021 to 2025 | $5,260,787 | April 1, 2009 | July 31, 2029 | FINKELSTEIN, AMY N. | reporter.nih.gov |
| Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $5,241,770 | August 22, 2022 | February 29, 2024 | ALLAND, DAVID | reporter.nih.gov |
| Supplement for MINI point-of-use device | NIH | National Institute on Drug Abuse | 2021 to 2022 | $5,188,351 | July 1, 2022 | December 31, 2023 | SOLO-GABRIELE, HELENA | reporter.nih.gov |
| Addressing alcohol misuse in HIV prevention and care: The Brown University Alcohol Research Center on HIV (ARCH) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $5,146,588 | September 30, 2010 | May 31, 2026 | KAHLER, CHRISTOPHER W. | reporter.nih.gov |
| Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD | NIH | National Institute on Aging | 2021 to 2025 | $5,121,493 | September 30, 2021 | May 31, 2027 | SPIRA, ADAM PETER | reporter.nih.gov |
| LINKAGE HONEST BROKER SERVICES FOR THE N3C DATA ENCLAVE | NIH | National Institute on Drug Abuse | 2024 to 2025 | $5,114,136 | March 1, 2024 | February 28, 2025 | GRANNIS, SHAUN | reporter.nih.gov |
| Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,112,288 | May 1, 2019 | April 30, 2029 | PASCUAL, MARIA VIRGINIA | reporter.nih.gov |
| Maternal SARS-CoV-2 infection, placenta biology, and neurodevelopmental outcomes in the offspring | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $5,085,297 | September 5, 2022 | July 31, 2027 | URSINI, GIANLUCA | reporter.nih.gov |
| RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROGRAM: PROJECT NO 5218 MATMACORP SARS-COV-2 HIGH THROUGHPUT LABORATORY CAPACITY SCALE-UP | NIH | National Heart, Lung, and Blood Institute | 2021 | $4,947,000 | August 29, 2020 | April 30, 2021 | KOZERA, PHIL | reporter.nih.gov |
| Effect of obesity on HIV pathogenesis, antiretroviral therapy, and metabolic comorbidities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $4,932,783 | September 10, 2019 | June 30, 2025 | ROBERTS, CHARLES T | reporter.nih.gov |
| The Historically Black Colleges/Universities and Communities Worker Health and Safety Training Program | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $4,913,625 | September 15, 2000 | May 31, 2025 | WRIGHT, BEVERLY L | reporter.nih.gov |
| Systems Approach to Immunity and Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,863,630 | September 1, 2012 | August 31, 2023 | ULEVITCH, RICHARD J | reporter.nih.gov |
| Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,817,583 | September 24, 2021 | August 31, 2024 | RODICK, ROBERT | reporter.nih.gov |
| The economic and social impact of pandemic mitigation policies: A cross-country analysis of macro events | NIH | National Institute on Aging | 2021 to 2025 | $4,809,580 | April 15, 2021 | January 31, 2027 | LILLARD, DEAN R | reporter.nih.gov |
| Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,799,861 | September 15, 2020 | August 31, 2025 | DIAMOND, MICHAEL S | reporter.nih.gov |
| Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $4,755,161 | September 25, 2024 | December 31, 2026 | PENNINI, MEGHAN | reporter.nih.gov |
| Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings. | NIH | National Institute on Drug Abuse | 2021 to 2022 | $4,752,331 | January 1, 2021 | May 31, 2024 | UHLEMANN, ANNE-CATRIN | reporter.nih.gov |
| NCATS LINKAGE HONEST BROKER (LHB) - PATIENT-CENTERED OUTCOMES RESEARCH (PCOR) TRUST FUND ASPE NATIONAL COVID-19 LONGITUDINAL RESEARCH DATABASE LINKED | NIH | National Institute on Drug Abuse | 2022 | $4,742,386 | March 1, 2022 | February 28, 2023 | TACHINARDI, UMBERTO | reporter.nih.gov |
| Multilevel Community-Based Mental Health Intervention to Address Health Disparities | NIH | National Institute of Mental Health | 2021 to 2025 | $4,726,164 | August 16, 2021 | July 31, 2026 | GOODKIND, JESSICA R | reporter.nih.gov |
| COVID-19 Mother Baby Outcomes (COMBO): brain-behavior functioning | NIH | National Institute of Mental Health | 2021 to 2025 | $4,681,303 | April 12, 2021 | January 31, 2027 | DUMITRIU, DANI | reporter.nih.gov |
| Hazardous Materials Worker Health and Safety Training | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $4,611,857 | September 16, 1992 | May 31, 2023 | ROSEN, MITCHEL A | reporter.nih.gov |
| Development of In Vitro Diagnostics for the Detection of SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $4,590,862 | June 1, 2023 | May 31, 2025 | SCHAUS, SCOTT | reporter.nih.gov |
| Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $4,504,502 | June 1, 2023 | August 31, 2025 | MANCEBO, RICARDO | reporter.nih.gov |
| Understanding Risk of Zoonotic Virus Emergence in EID Hotspots of Southeast Asia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,474,707 | June 17, 2020 | May 15, 2024 | DASZAK, PETER | reporter.nih.gov |
| Regulation of Protein C Pathways | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,441,427 | June 1, 2018 | March 31, 2026 | MOSNIER, LAURENT OLIVIER | reporter.nih.gov |
| DIGITAL HEALTH SOLUTIONS FOR COVID-19: PERSONALIZED ANALYTICS WEARABLE BIOSENSOR PLATFORM FOR EARLY DETECTION OF COVID-19 DECOMPENSATION | NIH | National Cancer Institute | 2021 | $4,338,693 | September 14, 2020 | September 13, 2021 | LARIMER, KAREN | reporter.nih.gov |
| Structure-function studies of the membrane-interacting domains of HIV-1 Env spike | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,299,010 | May 20, 2016 | June 30, 2027 | CHEN, BING | reporter.nih.gov |
| PROJECT MANAGEMENT SUPPORT FOR COMMUNITY ENGAGEMENT ON TRANS-NIH THERAPEUTICS AND VACCINE TRIALS | NIH | National Heart, Lung, and Blood Institute | 2021 | $4,297,649 | July 29, 2020 | January 28, 2021 | SHINGLEDECKER, DANIEL | reporter.nih.gov |
| Viral and immune-mediated CNS pathology during SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $4,269,302 | July 24, 2020 | June 30, 2025 | IWASAKI, AKIKO | reporter.nih.gov |
| Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,212,442 | June 15, 2021 | May 31, 2026 | KANNEGANTI, THIRUMALA-DEVI | reporter.nih.gov |
| A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx | NIH | National Institute of Mental Health | 2021 to 2025 | $4,199,975 | June 1, 2021 | May 31, 2027 | ALPERT, JONATHAN EDWARD | reporter.nih.gov |
| Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $4,174,965 | April 6, 2021 | April 5, 2023 | KIL, JONATHAN | reporter.nih.gov |
| Structure and Dynamics of the SARS-CoV-2 Spike Protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,142,443 | July 12, 2021 | June 30, 2027 | MOTHES, WALTHER H | reporter.nih.gov |
| Neural, Physiological, Behavioral, and Environmental Risk Markers of Anxiety from Infancy to Adolescence | NIH | National Institute of Mental Health | 2021 to 2025 | $4,141,334 | May 1, 1995 | May 31, 2027 | BOSQUET ENLOW, MICHELLE A | reporter.nih.gov |
| DIGITAL HEALTH SOLUTIONS FOR COVID-19: DIGITAL HEALTH PASS AND SMARTER CONTACT TRACING SOLUTIONS | NIH | National Cancer Institute | 2021 | $4,135,490 | September 14, 2020 | September 13, 2021 | GOETZEL, RON | reporter.nih.gov |
| Impact of Care Delivery and Therapeutic Changes on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $4,115,749 | September 30, 2021 | May 31, 2027 | HSU, JOHN | reporter.nih.gov |
| Computational examination of RDoC threat and reward constructs in a representative, predominantly low-income, longitudinal sample at increased risk for internalizing disorders (Admin Supplement) | NIH | National Institute of Mental Health | 2021 to 2024 | $4,115,209 | August 15, 2019 | June 30, 2025 | MONK, CHRISTOPHER STEPHEN | reporter.nih.gov |
| Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,981,418 | July 9, 2021 | December 31, 2026 | BAKER, SUSAN C. | reporter.nih.gov |
| RADX TECH - CERES NANOSCIENCE INC NANOTRAP PARTICLE MANUFACTURING | NIH | National Heart, Lung, and Blood Institute | 2021 | $3,974,000 | August 28, 2020 | May 31, 2021 | DUNLAP, ROSS | reporter.nih.gov |
| MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,967,038 | July 13, 2021 | June 30, 2027 | HOLLENBACH, JILL ALLISON | reporter.nih.gov |
| Wastewater Detection of COVID-19 | NIH | National Institute on Drug Abuse | 2021 to 2022 | $3,962,927 | January 1, 2021 | May 31, 2024 | WENZEL, JEFF | reporter.nih.gov |
| Prevention, Preparedness, and Response (P2R) Consortium | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,962,435 | August 17, 2010 | May 31, 2030 | RIOS, JANELLE | reporter.nih.gov |
| Establishment of a Bat Resource for Infectious Disease Research | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $3,960,972 | September 22, 2023 | August 31, 2028 | SCHOUNTZ, WILLIAM A | reporter.nih.gov |
| World Reference Center for Emerging Viruses and Arboviruses (WRCEVA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,949,988 | February 1, 2016 | March 24, 2025 | WEAVER, SCOTT C | reporter.nih.gov |
| Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,900,756 | February 1, 2022 | January 31, 2027 | SINGH, DHIRAJ KUMAR | reporter.nih.gov |
| Discovery of Adjuvants for mRNA Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,882,045 | September 30, 2025 | September 29, 2026 | CARSON, DENNIS | reporter.nih.gov |
| Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,866,300 | May 1, 2021 | March 31, 2026 | LEWIS, TENÉ T | reporter.nih.gov |
| Making Better Decisions: Policy Modeling for AIDS and Drug Abuse | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,865,844 | September 25, 2022 | January 31, 2029 | OWENS, DOUGLAS K | reporter.nih.gov |
| At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,843,434 | June 10, 2022 | May 31, 2027 | LAU, BRYAN | reporter.nih.gov |
| Optimizing a small molecule inhibitor of SARS-CoV-2 replication and associated cytokine storm | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,828,356 | September 1, 2021 | August 31, 2026 | GLENN, JEFFREY S | reporter.nih.gov |
| Understanding Pandemic Evolution through Networked Data (UPEND) | NIH | National Institute of Mental Health | 2023 | $3,822,251 | April 15, 2023 | April 14, 2026 | CROWELL, TREVOR ADAM | reporter.nih.gov |
| Sleep and health disparities among Asian Americans: roles of stressors and protective factors | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,796,997 | April 8, 2021 | January 31, 2027 | LEE, SUNMIN | reporter.nih.gov |
| Cell competition in pulmonary fibrosis and ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,796,920 | August 20, 2022 | July 31, 2029 | DE LANGHE, STIJN PIET JOHAN | reporter.nih.gov |
| Immune response to COVID-19 vaccine in HIV infected men and women | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,779,701 | September 23, 2021 | August 31, 2026 | RINALDO, CHARLES R | reporter.nih.gov |
| Mechanism and Inhibition of SARS-CoV-2 Entry | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,776,105 | July 8, 2021 | June 30, 2026 | WHELAN, SEAN PJ | reporter.nih.gov |
| Genetic Investigation of Covid 19 in Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,774,284 | August 1, 2022 | July 31, 2027 | KAHN, MARK L | reporter.nih.gov |
| Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,755,681 | September 17, 2021 | August 31, 2026 | ZANONI, IVAN | reporter.nih.gov |
| Next generation functional genomics of hematology traits | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,755,651 | February 1, 2020 | April 30, 2028 | REINER, ALEXANDER P | reporter.nih.gov |
| Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms | NIH | National Institute of Mental Health | 2021 to 2025 | $3,727,455 | September 15, 2021 | July 31, 2026 | MCCULLOUGH, LOUISE D. | reporter.nih.gov |
| Covid-19 Effects on Children & Families: 2021 Follow-Up of the PSID Child Development Supplement | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,726,095 | May 1, 2021 | February 28, 2026 | SASTRY, NARAYAN | reporter.nih.gov |
| Inborn errors of immunity in patients with life-threatening COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,707,765 | July 12, 2021 | June 30, 2026 | CASANOVA, JEAN-LAURENT | reporter.nih.gov |
| Leveraging genomic data to dissect the association of internalizing disorders with the risk, onset, and vulnerability of COVID-19 | NIH | National Institute of Mental Health | 2022 | $3,694,722 | September 1, 2022 | August 31, 2025 | POLIMANTI, RENATO | reporter.nih.gov |
| Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,689,933 | July 15, 2021 | June 30, 2026 | OZ, GULIN | reporter.nih.gov |
| Psychobiological Mechanisms Underlying the Association Between Early Life Stress and Depression Across Adolescence | NIH | National Institute of Mental Health | 2021 to 2025 | $3,666,643 | May 1, 2023 | February 29, 2028 | GOTLIB, IAN H | reporter.nih.gov |
| Advancing the development of a novel class of small molecules for treating pan-coronavirus infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,659,295 | August 10, 2021 | July 31, 2027 | EINAV, SHIRIT | reporter.nih.gov |
| Modeling and design of complex RNA structures | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,656,040 | September 1, 2017 | July 31, 2027 | DAS, RHIJU | reporter.nih.gov |
| Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19 | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $3,648,087 | September 25, 2021 | August 31, 2025 | GUSTAFSON, DAVID H | reporter.nih.gov |
| Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,639,039 | August 1, 2021 | July 31, 2027 | MOSCONA, ANNE | reporter.nih.gov |
| Post COVID-19 Neuro-Cognitive Manifestations and Underlying Mechanisms in Older African Americans | NIH | National Institute on Aging | 2022 | $3,612,360 | August 20, 2022 | July 31, 2025 | HAJJAR, IHAB M | reporter.nih.gov |
| Fusion inhibitors that block host-to-host transmission of SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,603,355 | August 1, 2021 | July 31, 2027 | POROTTO, MATTEO | reporter.nih.gov |
| Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,595,504 | February 1, 2022 | June 30, 2026 | SHAW, LESLEE J | reporter.nih.gov |
| The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,543,436 | March 1, 2022 | February 28, 2027 | TEIJARO, JOHN ROSS | reporter.nih.gov |
| SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort | NIH | National Institute on Aging | 2021 | $3,529,440 | September 1, 2021 | August 31, 2025 | SESHADRI, SUDHA | reporter.nih.gov |
| Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,517,747 | June 1, 2021 | February 28, 2027 | KHALILI, MANDANA | reporter.nih.gov |
| De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,504,899 | August 2, 2021 | July 31, 2026 | BAKER, DAVID | reporter.nih.gov |
| THE CONTRACTOR SHALL DEVELOP AN INFRASTRUCTURE TO INTEGRATE VARIOUS TYPES OF REAL WORLD DATA FROM A VARIETY OF CLINICAL AND NONCLINICAL SOURCES IN ORD | NIH | National Cancer Institute | 2021 | $3,492,171 | December 11, 2020 | December 10, 2021 | LEONARD, SANDY | reporter.nih.gov |
| Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study | NIH | National Institute of Mental Health | 2022 to 2025 | $3,477,672 | April 1, 2022 | January 31, 2027 | PEREZ RODRIGUEZ, MARIA DE LAS MERCEDES | reporter.nih.gov |
| Assessing the effectiveness of a digital platform to support the mental health of healthcare workers in the response and recovery phases of COVID-19 | NIH | National Institute of Mental Health | 2021 to 2023 | $3,420,329 | July 15, 2021 | June 30, 2025 | MERCHANT, RAINA | reporter.nih.gov |
| Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,417,860 | July 8, 2021 | June 30, 2027 | DENG, MARIO C. | reporter.nih.gov |
| Childhood, Adolescence, and Covid-Related Risk and Protective Factors in the Development of Adjustment in Early Adulthood Across Cultures | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,417,415 | September 30, 2007 | May 31, 2027 | LANSFORD, JENNIFER E | reporter.nih.gov |
| Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,416,984 | September 17, 2021 | August 31, 2026 | ACHARYA, PRIYAMVADA | reporter.nih.gov |
| Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia | NIH | National Institute on Aging | 2021 to 2022 | $3,416,459 | May 1, 2021 | August 31, 2022 | PAASCHE-ORLOW, MICHAEL | reporter.nih.gov |
| Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology | NIH | National Institute on Drug Abuse | 2021 to 2022 | $3,380,557 | January 1, 2021 | May 31, 2025 | BERRY, SCOTT M | reporter.nih.gov |
| Community-Centered Interventions for Improved Vaccine Uptake for COVID (CIVIC) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,378,034 | April 26, 2021 | May 9, 2025 | MARSH, ERICA E | reporter.nih.gov |
| Inhalation Therapy Platform for Coronavirus Infection Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,373,230 | September 17, 2021 | August 31, 2026 | STAYTON, PATRICK S. | reporter.nih.gov |
| mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression | NIH | National Institute of Mental Health | 2021 to 2023 | $3,366,058 | July 1, 2021 | June 30, 2026 | KUBO, AI | reporter.nih.gov |
| Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,354,566 | September 1, 2021 | July 31, 2027 | KIM, JIWON | reporter.nih.gov |
| Social Connectedness and Social Isolation in Nursing Home Residents | NIH | National Institute on Aging | 2021 to 2024 | $3,335,748 | June 1, 2021 | March 31, 2027 | LAPANE, KATE L | reporter.nih.gov |
| Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations | NIH | National Institute of Nursing Research | 2021 to 2023 | $3,333,396 | December 21, 2020 | November 30, 2023 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Longitudinal study of health outcomes and mitigating factors in the aftermath of the COVID pandemic | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,300,853 | September 21, 2021 | July 31, 2027 | MOHANAN, MANOJ | reporter.nih.gov |
| SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,300,000 | August 17, 2023 | July 31, 2026 | ALPERT, MICHAEL DAVID | reporter.nih.gov |
| Brief digital intervention to increase COVID-19 vaccination among individuals with anxiety or depression | NIH | National Institute of Mental Health | 2022 | $3,296,734 | September 1, 2022 | March 11, 2025 | NASH, DENIS | reporter.nih.gov |
| N3C OPEN DATA PORTAL AND COMMUNITY ENGAGEMENT SUPPORT SERVICES FOR NCATS (COVID-19 ACTION) | NIH | National Institute on Drug Abuse | 2022 | $3,295,541 | September 2, 2022 | September 1, 2023 | SHARMA, SUHAS | reporter.nih.gov |
| Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $3,292,532 | September 17, 2021 | August 31, 2027 | WISCHMEYER, PAUL E | reporter.nih.gov |
| Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,290,000 | July 1, 2021 | April 30, 2027 | MONTELIONE, GAETANO T | reporter.nih.gov |
| Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-types | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,271,583 | July 15, 2022 | June 30, 2027 | ESTIRI, HOSSEIN | reporter.nih.gov |
| Broad-spectrum therapeutics against SARS-CoV-2 3CL protease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,268,877 | August 19, 2021 | July 31, 2026 | SCHINAZI, RAYMOND FELIX | reporter.nih.gov |
| Palliative Care Research Cooperative Group (PCRC): Refinement and Expansion | NIH | National Institute of Nursing Research | 2021 to 2022 | $3,268,072 | September 28, 2013 | June 30, 2023 | KUTNER, JEAN S | reporter.nih.gov |
| Engineering the Skin Immune System to Induce Systemic Immune Responses | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,251,899 | March 4, 2021 | January 31, 2027 | FALO, LOUIS D | reporter.nih.gov |
| Longitudinal determination of nervous system consequences of SARS-CoV-2 in virologically suppressed people with HIV-1 treated in early infection | NIH | National Institute of Mental Health | 2022 | $3,249,942 | September 16, 2022 | September 15, 2025 | SPUDICH, SERENA S | reporter.nih.gov |
| Evolution of T cell immunity in blood and tissues over childhood | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,243,813 | March 16, 2022 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| ImpAct of COVID-19 on CaRe TransitOns and Health OutcomeS for Vulnerable PopulationS in Nursing Homes and Home HealthCARE Agencies (ACROSS-CARE) | NIH | National Institute on Aging | 2021 to 2024 | $3,235,483 | September 1, 2021 | April 30, 2026 | SHANG, JINGJING | reporter.nih.gov |
| Leveraging Longitudinal Survey and EHR data to Dissect the Impact of COVID-19 related Stressors and Infections on Child Mental Health and Suicide Risks | NIH | National Institute of Mental Health | 2023 | $3,231,590 | September 1, 2023 | August 31, 2026 | XIAO, YUNYU | reporter.nih.gov |
| Dissemination and Implementation of COVID-19 Care Innovations in ED Settings | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,230,156 | March 4, 2022 | February 28, 2026 | MENDEL, PETER JAMES | reporter.nih.gov |
| A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,217,894 | August 4, 2023 | July 31, 2027 | SHOEMAKER, CHARLES BIX | reporter.nih.gov |
| The epigenetic regulation of inflammation in tissue repair and vascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,217,378 | July 1, 2023 | June 30, 2030 | GALLAGHER, KATHERINE ANN | reporter.nih.gov |
| Uncovering associations of variant infection with COVID-19 disease severity in children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $3,214,599 | January 1, 2021 | June 30, 2023 | CHIU, CHARLES YEN | reporter.nih.gov |
| Strengthening the Safety Net: Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program | NIH | National Institute of Mental Health | 2021 to 2025 | $3,212,662 | July 1, 2021 | April 30, 2027 | NASH, DENIS | reporter.nih.gov |
| To Develop and Manufacture an Inactivated SARS-CoV-2 Vaccine Using Blood Pathogen Reduction Technology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,181,780 | September 1, 2020 | April 30, 2026 | GOODRICH, RAYMOND | reporter.nih.gov |
| Targeted Gene Delivery Systems Treating Lung Diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,172,072 | June 15, 2022 | May 31, 2026 | TIRRELL, MATTHEW | reporter.nih.gov |
| Development of peptide nucleic acid antibiotics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,164,488 | February 10, 2021 | January 31, 2025 | ARYA, DEV PRIYA | reporter.nih.gov |
| Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,161,127 | August 1, 2021 | July 31, 2027 | GUPTA, YOGESH K | reporter.nih.gov |
| Early life B cell responses and inflammation following SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,160,521 | September 17, 2021 | August 31, 2026 | FOUDA AMOU OU, GENEVIEVE GINY | reporter.nih.gov |
| International evaluation of modifiable social determinants of health on COVID-related mental health outcomes | NIH | National Institute of Mental Health | 2023 | $3,155,102 | August 2, 2023 | July 31, 2026 | SMOLLER, JORDAN W | reporter.nih.gov |
| Epitope-focused vaccine strategies against Zika virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $3,153,813 | August 1, 2018 | July 31, 2023 | NUSSENZWEIG, MICHEL C | reporter.nih.gov |
| RADX TECH - MAXIM BIOMEDICAL INC. SARS-COV-2 ANTIGEN RAPID TEST | NIH | National Heart, Lung, and Blood Institute | 2021 | $3,153,450 | August 28, 2020 | August 27, 2021 | MAA, JONATHAN | reporter.nih.gov |
| System Biological Analyses of Innate and Adaptive Responses to Vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $3,147,703 | March 1, 2021 | June 30, 2023 | PULENDRAN, BALI | reporter.nih.gov |
| Mechanisms of atherosclerotic cardiovascular complications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,538 | September 1, 2022 | August 31, 2026 | GIANNARELLI, CHIARA | reporter.nih.gov |
| VALE+TU SALUD: CORNER-BASED RANDOMIZED TRIAL TO TEST A LATINO DAY LABORER PROGRAM ADAPTED TO PREVENT COVID 19 | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,133,782 | July 10, 2021 | March 31, 2027 | FERNANDEZ-ESQUER, MARIA EUGENIA | reporter.nih.gov |
| Brain pathophysiology in SARS-CoV-2 disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,121,854 | July 1, 2021 | April 30, 2027 | SANDBERG, KATHRYN L | reporter.nih.gov |
| Tailored Behavioral Intervention to Prevent Household and Community Spread of COVID-19 among Latinos | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,120,476 | June 10, 2021 | February 28, 2027 | CRESPO, NOE CUAUHTEMOC | reporter.nih.gov |
| Structure, function, and inhibition of the SARS-CoV-2 replication-transcription complex | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,120,244 | August 6, 2021 | July 31, 2026 | DARST, SETH A. | reporter.nih.gov |
| Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,116,400 | September 17, 2021 | August 31, 2027 | LOONEY, MARK ROBERTS | reporter.nih.gov |
| Structural interrogation of vaccine- and infection-induced B cell responses | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,116,277 | February 22, 2022 | January 31, 2027 | BAJIC, GORAN | reporter.nih.gov |
| Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,114,564 | January 20, 2022 | December 31, 2026 | CHIRINOS MEDINA, JULIO ALONSO | reporter.nih.gov |
| Novel diagnostic tools and animal model system for study human/animal interface of COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,106,582 | September 17, 2021 | August 31, 2025 | FANG, YING | reporter.nih.gov |
| Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,102,338 | September 18, 2020 | August 31, 2025 | HASELTON, FREDERICK R | reporter.nih.gov |
| Psychological symptoms in healthcare workers following the COVID-19 pandemic and relationship to long-term cardiovascular risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,099,293 | February 1, 2022 | January 31, 2027 | CHANG, BERNARD P. | reporter.nih.gov |
| The impact of T cell selection on vaccine durability | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,085,906 | September 24, 2021 | August 31, 2027 | SU, LAURA | reporter.nih.gov |
| Optimizing lipid RVn monophosphate prodrugs to maximize RVn-triphosphate delivery | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,082,513 | July 18, 2025 | June 30, 2029 | CARLIN, AARON F. | reporter.nih.gov |
| Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,077,210 | April 23, 2021 | January 31, 2027 | SKAATHUN, BRITT | reporter.nih.gov |
| The Impact of the COVID-19 Pandemic on Severe Mental Illness | NIH | National Institute of Mental Health | 2023 | $3,072,053 | April 15, 2023 | April 14, 2026 | FREIMER, NELSON B. | reporter.nih.gov |
| Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,071,572 | September 16, 2021 | August 31, 2025 | RAY, ANIMESH | reporter.nih.gov |
| Elucidation of Assembly and Budding Mechanisms of SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,067,049 | September 19, 2022 | July 31, 2027 | STAHELIN, ROBERT VIRGIL | reporter.nih.gov |
| Novel delivery platform and antigen design for an effective COVID-19 vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,066,236 | August 11, 2020 | July 31, 2027 | MITTAL, SURESH K | reporter.nih.gov |
| Genetic Analysis of COVID-19 Susceptibility and Resistance Determinants in the Collaborative Cross | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,064,576 | September 25, 2020 | August 31, 2025 | HEISE, MARK T | reporter.nih.gov |
| A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,049,476 | April 1, 2021 | July 31, 2025 | YEH, ROBERT | reporter.nih.gov |
| CoPARC: Colorado Pulmonary-Alcohol Research Collaborative | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $3,045,581 | August 1, 2011 | April 30, 2029 | BURNHAM, ELLEN L | reporter.nih.gov |
| “Overlapping and Discrete Pathways Through Which Prenatal Isolation and Uncertainty Stress Impact Maternal Mental Health and Child Neurodevelopment | NIH | National Institute of Mental Health | 2021 to 2024 | $3,044,729 | May 15, 2021 | March 31, 2026 | THOMASON, MORIAH E | reporter.nih.gov |
| Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,044,448 | July 9, 2020 | June 30, 2027 | DU, LANYING | reporter.nih.gov |
| SARS-CoV-2 initiation and acceleration of AD pathology in the setting of endogenous and exogenous risk factors | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $3,039,032 | August 15, 2025 | July 31, 2029 | ANNAPRAGADA, ANANTH V | reporter.nih.gov |
| Using Disadvantage Indices in Pandemic Vaccine Allocation and Beyond to Promote Health Opportunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,031,954 | July 1, 2022 | June 30, 2027 | SCHMIDT, THOMAS HARALD | reporter.nih.gov |
| Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,026,517 | February 1, 2022 | January 31, 2027 | ACHARYA, PRIYAMVADA | reporter.nih.gov |
| Functional Lung Imaging Using a Single kV CT Acquisition | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,023,272 | July 1, 2021 | June 30, 2026 | CHEN, GUANG-HONG | reporter.nih.gov |
| Clonal Dynamics of the antibody response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,017,736 | January 1, 2017 | December 31, 2026 | VICTORA, GABRIEL D | reporter.nih.gov |
| Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,999,998 | June 7, 2023 | May 31, 2027 | COBURN, GLEN | reporter.nih.gov |
| Increasing Availability of Emulsion Adjuvants via Synthetic Biology | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $2,996,311 | August 30, 2022 | August 29, 2025 | KEMPINSKI, CHASE | reporter.nih.gov |
| Cell entry, cross-species transmission and pathogenesis of novel coronavirus from | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,992,324 | April 20, 2015 | August 31, 2025 | BARIC, RALPH S | reporter.nih.gov |
| A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,985,316 | July 12, 2022 | June 30, 2027 | SALEMI, MARCO | reporter.nih.gov |
| Transcending COVID-19 barriers to pain care in rural America: Pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain | NIH | National Institute of Nursing Research | 2021 to 2023 | $2,982,292 | June 10, 2021 | September 30, 2025 | SPIEGEL, BRENNAN | reporter.nih.gov |
| Reducing COVID-related PTSD symptoms in Frontline Healthcare Workers through Trauma-Focused Treatment in Employee Assistance Programs | NIH | National Institute of Mental Health | 2022 to 2025 | $2,977,008 | September 1, 2022 | June 30, 2027 | SRIPADA, REBECCA KAUFMAN | reporter.nih.gov |
| Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,966,398 | July 19, 2024 | May 31, 2029 | CHANG, KYEONG-OK | reporter.nih.gov |
| Optimizing a Personalized Health Approach for Virtually Treating High-Risk Caregivers During COVID-19 and Beyond | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,963,721 | September 23, 2022 | June 30, 2026 | KELLEHER, BRIDGETTE LYNNE | reporter.nih.gov |
| Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,960,871 | April 1, 2016 | February 28, 2026 | CHENG, SUSAN | reporter.nih.gov |
| Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults | NIH | National Institute on Aging | 2022 to 2025 | $2,954,828 | July 1, 2022 | June 30, 2027 | SCHIFITTO, GIOVANNI | reporter.nih.gov |
| Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,948,542 | September 23, 2022 | August 31, 2026 | YAN, JUN | reporter.nih.gov |
| Developing a Multi-epitope Pan-Coronavirus Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,944,787 | August 7, 2020 | July 31, 2025 | BENMOHAMED, LBACHIR | reporter.nih.gov |
| Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,942,639 | July 1, 2023 | June 30, 2027 | KIEVIT, PAUL | reporter.nih.gov |
| Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,941,237 | February 1, 2022 | January 31, 2027 | REHMAN, JALEES | reporter.nih.gov |
| Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,938,841 | May 10, 2022 | June 30, 2024 | KRAMS, SHERI M. | reporter.nih.gov |
| ACE2 immunodecoys for long-lasting immunoprophylaxis against sarbecovirus and merbecoviruses that target human ACE2 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,937,578 | August 18, 2025 | July 31, 2029 | LAI, SAMUEL | reporter.nih.gov |
| Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,933,325 | April 1, 2022 | March 31, 2026 | MISHARIN, ALEXANDER | reporter.nih.gov |
| Human coronavirus infection of the nasal epithelium | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,932,769 | September 20, 2022 | July 31, 2027 | WEISS, SUSAN R | reporter.nih.gov |
| DIGITAL HEALTH SOLUTIONS FOR COVID-19: COVID COMMUNITY ACTION AND RESEARCH ENGAGEMENT (COVID-CARE) | NIH | National Cancer Institute | 2021 | $2,927,659 | September 14, 2020 | September 13, 2021 | JAIN, PRADUMAN | reporter.nih.gov |
| Dynamic Strategies for the clinical management of HIV disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,926,858 | August 9, 2012 | May 31, 2028 | HERNAN, MIGUEL | reporter.nih.gov |
| REDES: a peer network and mobile health (mHealth) enhanced CHW model to maximize COVID-19 vaccination among low income Latinos | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,925,112 | April 13, 2022 | October 31, 2027 | PAGE, KATHLEEN R | reporter.nih.gov |
| National Consortium on Alcohol and Neurodevelopment in Adolescence: OHSU | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,925,071 | September 15, 2012 | June 30, 2027 | NAGEL, BONNIE J. | reporter.nih.gov |
| Diagnosing and predicting risk in children with SARS-CoV-2- related illness | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $2,924,117 | January 1, 2021 | November 30, 2024 | BURNS, JANE C | reporter.nih.gov |
| Clinical analysis and therapeutic development of exosomal ACE2 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,922,951 | July 15, 2022 | June 30, 2027 | LIU, HUIPING | reporter.nih.gov |
| Innate immune responses to SARS-CoV-2 infection in the olfactory epithelium | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $2,922,855 | April 1, 2022 | March 31, 2027 | GONG, QIZHI | reporter.nih.gov |
| Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,917,054 | June 1, 2022 | May 31, 2027 | WONG, PAMELA TINMOI | reporter.nih.gov |
| 2/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,915,073 | May 1, 2023 | April 30, 2027 | LU, MICHAEL TSE-YIN | reporter.nih.gov |
| Investigating neurobehavioral consequences of COVID-19 related stressors on maternal mental health and infant development | NIH | National Institute of Mental Health | 2021 to 2024 | $2,914,615 | June 1, 2021 | March 31, 2026 | BRITO, NATALIE HIROMI | reporter.nih.gov |
| Evidence-Informed Mental health Prevention, Assessment, Collaboration, and Treatment in Middle Schools (E-IMPACTS) | NIH | National Institute of Mental Health | 2022 | $2,910,771 | September 1, 2022 | August 31, 2025 | LYONS, MICHAEL D | reporter.nih.gov |
| iPSC-Derived Vascularized Human Lung Organoids and Interaction Between Lung Endothelial Cells and Alveolar Epithelial Cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,907,792 | August 1, 2022 | May 31, 2027 | REHMAN, JALEES | reporter.nih.gov |
| Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers | NIH | National Institute of Mental Health | 2023 | $2,906,437 | May 1, 2023 | April 30, 2026 | RUBIN, LEAH HELANE | reporter.nih.gov |
| Automated Contact Tracing System for Rapid High-Accuracy Assessment to Management Dementia Patients and Staff Exposed to Infectious Diseases in Long Term Care Facilities | NIH | National Institute on Aging | 2021 to 2023 | $2,899,569 | September 1, 2021 | August 31, 2025 | SHEIKH, SUNEEL ISMAIL | reporter.nih.gov |
| Kinetic and structural basis for SARS-CoV-2 RNA-dependent RNA polymerase specificity and inhibition | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,889,190 | July 16, 2021 | June 30, 2027 | JOHNSON, KENNETH ALLEN | reporter.nih.gov |
| Role of Complement Activation in Severe COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,886,906 | August 20, 2022 | July 31, 2026 | QIN, XUEBIN | reporter.nih.gov |
| Multi-level evidence-based intervention to reduce health and education disparities among children of color in high-poverty schools in historically disinvested neighborhoods hardest hit by the pandemic | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,878,623 | September 24, 2021 | July 31, 2025 | BROTMAN, LAURIE MILLER | reporter.nih.gov |
| Natural Killer cells and the Immunogenetics of COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,878,562 | September 1, 2021 | August 31, 2025 | NORMAN, PAUL JOHN | reporter.nih.gov |
| Community-based Design and Evaluation of a Conversational Agent to Promote SARS-COV2 Vaccination in Black Churches | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,872,823 | April 23, 2021 | April 1, 2025 | BICKMORE, TIMOTHY W. | reporter.nih.gov |
| Mechanistic dissection of eukaryotic protein biogenesis and degradation pathways | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,867,438 | April 1, 2018 | June 30, 2028 | DENIC, VLADIMIR | reporter.nih.gov |
| VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,865,878 | February 15, 2022 | January 31, 2027 | NEMATI, SHAMIM | reporter.nih.gov |
| Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,853,123 | January 8, 2019 | December 31, 2025 | PLEMPER, RICHARD K. | reporter.nih.gov |
| A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,852,667 | May 7, 2024 | April 30, 2029 | CHEW, KARA W | reporter.nih.gov |
| Adolescent health behaviors in the time of COVID-19 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,852,328 | August 20, 2021 | June 30, 2026 | YBARRA, MICHELE L. | reporter.nih.gov |
| The longer-term impact of prenatal exposure to SARS-CoV-2 infection and the COVID-19 vaccine on behavior, cognition, and brain functioning in the child | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,848,362 | August 19, 2022 | June 30, 2027 | ROMMEL, ANNA-SOPHIE | reporter.nih.gov |
| Studying How State and Local Health Services Delivery Policies can Mitigate the Effects of Disasters on Drug Addiction Treatment and Overdose: A Mixed-Methods Study of COVID-19. | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,829,066 | August 1, 2021 | May 31, 2026 | EISENBERG, MATTHEW | reporter.nih.gov |
| Betacoronaviruses: activation and antagonism of host innate immune responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,828,524 | May 24, 2018 | April 30, 2028 | WEISS, SUSAN R | reporter.nih.gov |
| Basic Research for Diagnostics and Surveillance in Lower Resource Environments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,825,608 | August 12, 2021 | July 31, 2025 | BENNER, STEVEN A | reporter.nih.gov |
| Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chip | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,824,730 | May 1, 2021 | April 30, 2026 | CONNOR, JOHN H | reporter.nih.gov |
| MIT Roybal Center for Translational Research to Improve Healthcare for the Aging | NIH | National Institute on Aging | 2021 to 2024 | $2,819,781 | July 15, 2020 | May 31, 2025 | FINKELSTEIN, AMY N. | reporter.nih.gov |
| Broadly neutralizing SARS-CoV-2 peptidic knobs | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,809,275 | June 9, 2023 | May 31, 2028 | SMIDER, VAUGHN VASIL | reporter.nih.gov |
| Prescribing trends and associated outcomes of antiepileptic drugs and other psychoactive medications in US nursing homes surrounding the COVID-19 pandemic | NIH | National Institute on Aging | 2022 to 2025 | $2,807,595 | September 1, 2022 | June 30, 2027 | WINTER, JONATHAN DAVID | reporter.nih.gov |
| Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus | NIH | National Eye Institute | 2022 to 2023 | $2,806,822 | September 30, 2016 | July 31, 2023 | COHEN, ELISABETH J | reporter.nih.gov |
| Randomized controlled trial of a novel digital health solution to enable remote fetal monitoring in high risk pregnancies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,806,771 | September 20, 2021 | August 31, 2025 | SCHWARTZ, NADAV | reporter.nih.gov |
| Wastewater Analysis of SARS CoV-2 in Tribal Communities | NIH | National Institute on Drug Abuse | 2021 to 2022 | $2,800,280 | January 1, 2021 | May 31, 2024 | CONROY-BEN, OTAKUYE | reporter.nih.gov |
| Leveraging community health workers to improve SARS-CoV-2 testing and mitigation among criminal justice-involved individuals accessing a corrections-focused community-based organization | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,799,543 | September 21, 2021 | May 31, 2026 | AKIYAMA, MATTHEW | reporter.nih.gov |
| Telehealth 2.0: Evaluating effectiveness and engagement strategies for asynchronous texting based trauma focused therapy for PTSD | NIH | National Institute of Mental Health | 2021 | $2,792,355 | September 17, 2021 | September 16, 2025 | WILTSEY STIRMAN, SHANNON | reporter.nih.gov |
| COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,791,226 | July 15, 2021 | April 30, 2026 | OELSNER, ELIZABETH | reporter.nih.gov |
| Telehealth policy expansion's impact on patient care & mental health | NIH | National Institute of Mental Health | 2023 | $2,790,468 | May 15, 2023 | May 14, 2026 | LEUNG, LUCINDA B | reporter.nih.gov |
| Family Dynamics, Fertility and Contraception, and Investments in Children across Generations | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,789,380 | April 1, 2022 | January 31, 2027 | CROSSLEY, THOMAS FRASER | reporter.nih.gov |
| Structural Dynamics of Translation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,788,997 | September 1, 2021 | August 31, 2027 | ERMOLENKO, DMITRI | reporter.nih.gov |
| Mechanisms of regulatory T cell-mediated recovery from severe viral pneumonia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,783,450 | March 1, 2020 | June 30, 2029 | SINGER, BENJAMIN DAVID | reporter.nih.gov |
| Mobile Health to Monitor Risk for COVID-19 and Improve Mental Health during the Pandemic | NIH | National Institute of Mental Health | 2021 to 2023 | $2,770,560 | May 5, 2021 | March 31, 2025 | ZVOLENSKY, MICHAEL J. | reporter.nih.gov |
| Discovery of SARS-CoV-2 antivirals using a replicon assay | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,764,202 | August 1, 2022 | July 31, 2027 | SARAFIANOS, STEFAN G | reporter.nih.gov |
| TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,759,863 | September 1, 2022 | August 31, 2026 | CHEN, YA-WEN | reporter.nih.gov |
| Modeling the Coupled Dynamics of COVID-19 Transmission and Protective Behaviors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,758,288 | September 17, 2021 | August 31, 2027 | PARKER, ANDREW | reporter.nih.gov |
| Long-Term Endothelial Effects of COVID-19 in Obesity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,750,534 | March 15, 2022 | February 28, 2026 | HO, JENNIFER E | reporter.nih.gov |
| Impact of Perinatal Pandemic-Related Stress on the Early Caregiving Environment, Infant Functioning, DNA Methylation, and Telomere Length | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,748,498 | April 1, 2021 | March 31, 2026 | GRASSO, DAMION JOSEPH | reporter.nih.gov |
| Antibody Durability Dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,745,532 | July 1, 2022 | June 30, 2027 | WESEMANN, DUANE R. | reporter.nih.gov |
| Development and characterization of engineered therapeutic antibodies against SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,738,360 | August 1, 2021 | July 31, 2024 | AMARASINGHE, GAYA K. | reporter.nih.gov |
| ECHO Renewal for the CANOE Study Cohort | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,735,209 | September 1, 2023 | May 31, 2026 | HARTERT, TINA V | reporter.nih.gov |
| Immunologic basis of cardiac disease after severe COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,713,482 | July 1, 2022 | May 31, 2027 | SHENOY, CHETAN | reporter.nih.gov |
| CYTOF AND O-LINK ASSESSMENT IN THE `NCI COVID-19 IN CANCER PATIENTS STUDY' (NCCAPS) | NIH | National Cancer Institute | 2021 | $2,712,342 | December 23, 2020 | December 22, 2021 | GNJATIC, SACHA | reporter.nih.gov |
| DIGITAL HEALTH SOLUTIONS FOR COVID-19 | NIH | National Cancer Institute | 2021 | $2,711,605 | September 14, 2020 | September 13, 2021 | WALTON, ROBERT | reporter.nih.gov |
| Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities | NIH | National Institute of Nursing Research | 2021 to 2024 | $2,710,921 | May 14, 2021 | March 31, 2026 | WALLACE, ANDREA SCHNEIDER | reporter.nih.gov |
| Coronavirus Genome Replication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,704,705 | March 15, 2021 | February 28, 2027 | CAMERON, CRAIG E. | reporter.nih.gov |
| Alaska Native Communities Advancing Vaccine Uptake | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,702,576 | August 18, 2022 | July 31, 2027 | BEANS, JULIE | reporter.nih.gov |
| COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City. | NIH | National Institute on Aging | 2022 to 2025 | $2,701,968 | September 30, 2022 | June 30, 2027 | DODSON, JOHN A | reporter.nih.gov |
| Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $2,699,469 | September 1, 2020 | August 31, 2022 | BARIC, RALPH S | reporter.nih.gov |
| Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,698,545 | April 1, 2022 | March 31, 2027 | DAILY, JOHANNA PATRICIA | reporter.nih.gov |
| The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa | NIH | National Institute of Mental Health | 2023 | $2,696,906 | August 15, 2023 | August 14, 2026 | KANE, JEREMY CALVIN | reporter.nih.gov |
| A risk-varying and perturbed self-controlled case series design for assessing the safety of COVID-19 vaccines in a large health care system | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,691,275 | May 17, 2022 | April 30, 2027 | XU, STANLEY | reporter.nih.gov |
| Cellular effects of SARS-CoV-2 in mediating thrombotic susceptibility | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,674,669 | February 9, 2022 | January 31, 2027 | DAYAL, SANJANA | reporter.nih.gov |
| The impact of social isolation on aging health in schizophrenia | NIH | National Institute of Mental Health | 2022 to 2025 | $2,674,394 | August 15, 2022 | May 31, 2027 | REICHENBERG, ABRAHAM | reporter.nih.gov |
| COVID Transmission and Morbidity in Malawi (COVID-TMM) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,666,340 | April 1, 2025 | March 31, 2027 | VALIM, CLARISSA | reporter.nih.gov |
| Prenatal to Preschool: The Impact of the Pandemic on Mothers and children, with a focus on syndemic effects on Black families | NIH | National Institute of Mental Health | 2022 to 2025 | $2,666,187 | July 6, 2022 | May 31, 2027 | NJOROGE, WANJIKU FELICIA MBUGUA | reporter.nih.gov |
| AMPK Regulation of ACE2 in Endothelial Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,666,121 | February 15, 2022 | January 31, 2026 | SHYY, JOHN YJ | reporter.nih.gov |
| Fusion peptide directed immunogens that elicit neutralizing and protective antibodies in non-human primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,658,042 | March 18, 2019 | February 28, 2025 | WARD, ANDREW BARRETT | reporter.nih.gov |
| Administrative Supplement to Investigate the Effects of Long COVID on SELA study participants | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,657,323 | July 28, 2021 | April 30, 2026 | RAMOS, PAULA SOFIA | reporter.nih.gov |
| The impact of COVID-19 pandemic-related stressors on childhood obesity and cardiometabolic risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,655,340 | September 19, 2022 | June 30, 2027 | KUNIN-BATSON, ALICIA S | reporter.nih.gov |
| Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,655,001 | September 17, 2021 | August 31, 2025 | MARASCO, WAYNE A. | reporter.nih.gov |
| Structural studies of viral replication and invasion | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,649,373 | July 1, 2016 | December 31, 2026 | AIHARA, HIDEKI | reporter.nih.gov |
| Mitigating effects of telehealth uptake on disparities in maternal care access, quality, outcomes, and expenditures during the COVID-19 pandemic | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,636,399 | September 15, 2022 | April 30, 2027 | HUNG, PEIYIN | reporter.nih.gov |
| B-cell response and thrombotic complications in COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,626,288 | February 1, 2022 | January 31, 2027 | WEN, RENREN | reporter.nih.gov |
| Regulation of germinal center responses by SARS-CoV-2 messenger RNA vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,622,660 | February 9, 2022 | January 31, 2027 | LOCCI, MICHELA | reporter.nih.gov |
| Quantifying Error Growth to Improve Infectious Disease Forecast Accuracy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,622,260 | June 9, 2021 | May 31, 2027 | SHAMAN, JEFFREY L | reporter.nih.gov |
| Balancing epithelial cell resistance and resilience to respiratory viral infections | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,621,215 | January 1, 2023 | December 31, 2027 | ORDOVAS-MONTANES, JOSE MANUEL | reporter.nih.gov |
| Systems modeling to address the social and biological drivers of disparities in infection and mortality from emerging infectious diseases | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,614,508 | July 20, 2022 | November 30, 2027 | ZELNER, JONATHAN L | reporter.nih.gov |
| Racial and Ethnic Disparities in Hepatocellular Carcinoma Surveillance Among Patients with Cirrhosis Across Five Safety Net Organizations | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,613,442 | December 22, 2021 | November 30, 2026 | WONG, ROBERT JOHN | reporter.nih.gov |
| Risk Factors for AIDS among persons who inject drugs: HIV transmission during and after the pandemic | NIH | National Institute on Drug Abuse | 2021 to 2025 | $2,592,727 | September 10, 1994 | May 31, 2027 | MCKNIGHT, COURTNEY | reporter.nih.gov |
| Viral Noncoding RNAs and Cell Transformation | NIH | National Cancer Institute | 2022 to 2025 | $2,579,432 | January 20, 2022 | December 31, 2026 | STEITZ, JOAN A. | reporter.nih.gov |
| Long-Term Impact of the COVID-19 Pandemic on Self-Management of Chronic Conditions: The C3 Study | NIH | National Institute on Aging | 2022 to 2025 | $2,566,628 | June 1, 2022 | March 31, 2027 | WOLF, MICHAEL S | reporter.nih.gov |
| A National Neighborhood Data Resource to Understand the Health and Socioeconomic Impacts of the 2020 Pandemic in the United States | NIH | National Institute of Nursing Research | 2022 to 2025 | $2,565,639 | April 14, 2022 | January 31, 2027 | CLARKE, PHILIPPA | reporter.nih.gov |
| Function interactions between mitogen-activated protein kinases (MAPKs) and SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,563,708 | March 13, 2023 | February 29, 2028 | JOHNSON, JEFFREY R | reporter.nih.gov |
| Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health | NIH | National Institute on Aging | 2023 | $2,561,480 | September 1, 2023 | August 31, 2026 | HU, HUI | reporter.nih.gov |
| Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,561,391 | May 1, 2021 | April 30, 2029 | BIRBECK, GRETCHEN L. | reporter.nih.gov |
| Cellular models of fetal neurodevelopment in maternal SARS-CoV-2 infection | NIH | National Institute of Mental Health | 2022 | $2,560,905 | September 15, 2022 | September 14, 2025 | EDLOW, ANDREA GOLDBERG | reporter.nih.gov |
| Characterization of Persistent COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,560,715 | August 10, 2023 | July 31, 2027 | LI, JONATHAN | reporter.nih.gov |
| Targeting SARS-CoV-2 PLpro for COVID-19 treatment | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,558,532 | February 22, 2022 | January 31, 2027 | XIONG, RUI | reporter.nih.gov |
| Brain Function and Neurogenomic influences on AUD risk and resilience. | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $2,553,017 | September 20, 2021 | June 30, 2027 | PORJESZ, BERNICE | reporter.nih.gov |
| Impact of SARS-CoV-2 on the cerebrovasculature as a risk factor for VCID: Role of Wnt/beta-catenin | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $2,549,080 | August 11, 2025 | July 31, 2029 | LUTZ, SARAH ELIZABETH | reporter.nih.gov |
| Social connections, risk for COVID-era psychiatric and substance use disorders, and HIV control | NIH | National Institute of Mental Health | 2022 to 2025 | $2,548,499 | January 1, 2022 | October 31, 2026 | WILSON, TRACEY ELIZABETH | reporter.nih.gov |
| The origin and future protective activity of SARS-CoV-2 RBD specific neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,538,999 | September 17, 2021 | August 31, 2025 | KOBIE, JAMES J | reporter.nih.gov |
| Investigating the impacts of COVID-19 school closures on long-term adjustment in youth with or at risk for disability | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,531,885 | July 18, 2022 | May 31, 2027 | MCINTYRE, LAURA LEE | reporter.nih.gov |
| Long-Term Effects of COVID-19 and Health Care Delivery Changes on Populations Living with Multiple Chronic Conditions | NIH | National Institute on Aging | 2021 to 2025 | $2,529,660 | September 30, 2021 | May 31, 2026 | STANGE, KURT C | reporter.nih.gov |
| Genetic and Immuno-inflammatory Drivers of Post-acute Pulmonary Sequelae of SARS-CoV-2 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,526,022 | February 5, 2023 | January 31, 2028 | ABRAMSON, STEVEN B | reporter.nih.gov |
| Molecular mechanisms of aging and accelerated aging in the human brain | NIH | National Institute on Aging | 2023 to 2025 | $2,525,941 | September 15, 2023 | May 31, 2028 | MAVRIKAKI, MARIA | reporter.nih.gov |
| Dissecting the drivers of persistent SARS-CoV-2 infections | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,521,336 | July 17, 2023 | June 30, 2028 | SIMON, VIVIANA A | reporter.nih.gov |
| Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,516,194 | February 11, 2022 | January 31, 2027 | RICE, CHARLES M | reporter.nih.gov |
| Enhancing dengue virus genomic surveillance to uncover circulating genetic diversity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,514,500 | September 21, 2022 | August 31, 2027 | GRUBAUGH, NATHAN DALE | reporter.nih.gov |
| When pandemics collide: The intersection of the opioid crisis, COVID-19 and HIV pandemics among people who inject drugs in the United States | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,512,373 | September 30, 2020 | August 31, 2025 | GENBERG, BECKY LYNN | reporter.nih.gov |
| A multipronged investigation of SARS-CoV-2 genome packaging | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,505,582 | April 16, 2022 | March 31, 2027 | SORANNO, ANDREA | reporter.nih.gov |
| Mechanisms of Gastrointestinal COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,503,469 | July 15, 2022 | June 30, 2027 | CIORBA, MATTHEW AARON | reporter.nih.gov |
| The Impacts of Mitigation Strategies to Prevent COVID-19 Transmission in American Indian Communities | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,498,232 | May 25, 2021 | February 28, 2027 | AKEE, RANDALL K. Q. | reporter.nih.gov |
| Wirelessly controlled BSL3 vivarium system for automated microdosing in studies of infectious diseases | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $2,495,626 | August 1, 2021 | July 31, 2025 | HOANG, TUAN Q | reporter.nih.gov |
| K-VAC: Kentucky Vaccinating Appalachian Communities | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,489,189 | July 15, 2022 | March 31, 2028 | KIVINIEMI, MARC T | reporter.nih.gov |
| Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector Platform | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,482,547 | June 1, 2019 | May 31, 2025 | HORWITZ, MARCUS AARON | reporter.nih.gov |
| Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,477,786 | April 13, 2021 | March 31, 2026 | GRABOWSKI, MARY KATHRYN | reporter.nih.gov |
| Probing functioning lung at the cellular resolution in health and disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,475,000 | September 1, 2022 | August 31, 2027 | NIA, HADI TAVAKOLI | reporter.nih.gov |
| Pragmatic RCT of a multi-level mechanistically informed community intervention to prevent the onset of behavioral health symptoms among socioeconomically disadvantaged pandemic affected children | NIH | National Institute of Mental Health | 2022 to 2025 | $2,463,619 | August 1, 2022 | May 31, 2027 | LEYTHAM-POWELL, TARA | reporter.nih.gov |
| Control of Humoral and Cellular Immunity to Viral Infections of the Lung by Follicular CD8 T Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,450,710 | April 1, 2021 | March 31, 2026 | SAGE, PETER THE | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 2 BY ADDING ADDING COVID-19 FUNDS FOR THE PERIOD OF PERFORMANCE OF 1/1/21 TO 4/30/21. | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,444,259 | May 8, 2020 | April 30, 2021 | MARINO, MARK | reporter.nih.gov |
| SARS-CoV-2 Vaccine Responses in children with genetic or acquired B cell deficiencies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,443,721 | June 2, 2022 | May 31, 2026 | HSIEH, WEN-YUAN E | reporter.nih.gov |
| ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,443,104 | September 17, 2021 | August 31, 2025 | WILSON, DAVID M | reporter.nih.gov |
| The longitudinal impact of the COVID-19 pandemic and related multi-level mitigation and contextual factors on health and socioeconomic outcomes of individuals and families from a vulnerable population | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,440,978 | September 15, 2022 | April 30, 2027 | MITCHELL, COLTER M.S. | reporter.nih.gov |
| A binational cohort of the intersection between substance use, HIV, and associated comorbidities among people who inject drugs in San Diego, CA | NIH | National Institute on Drug Abuse | 2025 | $2,437,310 | July 15, 2025 | May 31, 2030 | STRATHDEE, STEFFANIE A. | reporter.nih.gov |
| Role and Mitigation of Inflammasomes and Inflammation During COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,428,594 | July 15, 2022 | June 30, 2027 | TING, JENNY P | reporter.nih.gov |
| The effect of HIV on SARS-CoV-2 transmission and emergence of variants of concern | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,428,046 | July 1, 2025 | June 30, 2027 | SHIN, SANGHYUK SAM | reporter.nih.gov |
| hHv1 channels in neutrophils and the innate immune inflammatory response | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,426,520 | August 5, 2022 | June 30, 2027 | GOLDSTEIN, STEVE A N | reporter.nih.gov |
| Reducing Racial Disparities in SMM post COVID19: Assessing the integration of maternal safety bundles and community based doulas to improve outcomes for Black women | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,426,119 | September 17, 2020 | June 30, 2025 | AMUTAH-ONUKAGHA, NDIDIAMAKA | reporter.nih.gov |
| Overriding the Immune Evasion Tactics of Coronavirus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,422,685 | August 12, 2020 | July 31, 2025 | WARE, CARL F | reporter.nih.gov |
| Mechanisms of IgM mediated activation of the complement system | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,422,075 | June 2, 2021 | May 31, 2026 | GUTTMAN, MIKLOS | reporter.nih.gov |
| Long term adverse health outcomes for women and children following SARS-CoV-2 infection during pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,418,045 | July 1, 2023 | June 30, 2028 | HEDDERSON, MONIQUE MARIE | reporter.nih.gov |
| Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,408,222 | July 1, 2023 | June 30, 2028 | WORGALL, STEFAN | reporter.nih.gov |
| Defining regulators of immunity to acute infection using CRISPR screens | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $2,402,306 | July 5, 2017 | June 30, 2023 | SHARPE, ARLENE H. | reporter.nih.gov |
| Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,400,464 | August 1, 2020 | July 31, 2024 | GANDHI, MONICA | reporter.nih.gov |
| Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,395,128 | September 21, 2022 | July 31, 2027 | PANNARAJ, PIA S | reporter.nih.gov |
| Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing | NIH | National Institute on Aging | 2023 | $2,394,473 | May 15, 2023 | April 30, 2026 | CHENG, FEIXIONG | reporter.nih.gov |
| Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,375,036 | August 28, 2023 | July 31, 2028 | O'CONNOR, MEGAN A | reporter.nih.gov |
| Investigating the role of Alpha5Beta1 integrin in cognitive dysfunction | NIH | National Institute on Aging | 2023 to 2024 | $2,373,215 | April 1, 2023 | March 31, 2026 | BIX, GREGORY JAYE | reporter.nih.gov |
| Covid 19 cytokine storm | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,371,605 | August 15, 2021 | July 31, 2025 | CHUGH, SUMANT SINGH | reporter.nih.gov |
| Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,371,262 | August 20, 2021 | June 30, 2026 | QUE, JIANWEN | reporter.nih.gov |
| Improving mental health among the LGBTQ+ community impacted by the COVID-19 pandemic | NIH | National Institute of Mental Health | 2022 | $2,368,492 | September 1, 2022 | February 28, 2025 | MOITRA, ETHAN | reporter.nih.gov |
| Cyclical Alterations In Neurocognitive Performance And Mood Over Two Years In Relation To Pesticide Spray Seasons Among Adolescent And Young Adult Participants Of The Espina Study. | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,368,195 | April 1, 2016 | February 28, 2027 | SUAREZ, JOSE RICARDO | reporter.nih.gov |
| Lipid Bilayer Remodeling and Protein Intermediates During Membrane Fusion | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,366,413 | July 25, 2022 | June 30, 2027 | LEE, KELLY KEISEN | reporter.nih.gov |
| Blood DNA Methylation Biomarkers of Post Acute Sequelae of SARS CoV 2 Infection (PASC) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,365,635 | July 5, 2023 | June 30, 2028 | JAITOVICH, ADOLFO ARIEL | reporter.nih.gov |
| Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,361,031 | April 15, 2023 | March 31, 2027 | KIM, DANIEL | reporter.nih.gov |
| SASEA | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $2,357,494 | January 7, 2022 | August 31, 2025 | FIELDING-MILLER, REBECCA KATHLEEN | reporter.nih.gov |
| Investigating and identifying the heterogeneity in COVID-19 misinformation exposure on social media among Black and Rural communities to inform precision public health messaging | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $2,356,413 | September 20, 2022 | March 20, 2025 | GUNTUKU, SHARATH CHANDRA | reporter.nih.gov |
| Host cellular network governing the development of post SARS-CoV-2 tissue sequelae | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,351,771 | February 14, 2020 | May 31, 2030 | SUN, JIE | reporter.nih.gov |
| Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments | NIH | National Institute on Aging | 2022 | $2,342,002 | May 1, 2022 | April 30, 2025 | XU, RONG | reporter.nih.gov |
| Developing three-dimensional antisense oligonucleotide drugs against COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,341,581 | July 19, 2021 | June 30, 2026 | GUO, FENG | reporter.nih.gov |
| Assessing the Long-term Impact of COVID-induced Telemedicine Expansion on Dementia Care | NIH | National Institute on Aging | 2022 | $2,340,878 | June 1, 2022 | May 31, 2025 | ADLER-MILSTEIN, JULIA ROSE | reporter.nih.gov |
| Anticipating and rapidly responding to respiratory virus outbreaks with continuous air sampling in K-12 schools | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,302 | January 18, 2023 | December 31, 2027 | O'CONNOR, DAVID H. | reporter.nih.gov |
| COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk | NIH | National Institute on Aging | 2023 to 2025 | $2,337,162 | December 15, 2022 | November 30, 2027 | REAS, EMILIE T. | reporter.nih.gov |
| Unwinding pandemic-era social programs: Effects on healthcare outcomes and disparities | NIH | National Institute of Nursing Research | 2023 | $2,332,008 | September 19, 2023 | August 31, 2026 | SONIK, RAJAN ANTHONY | reporter.nih.gov |
| Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,330,378 | July 21, 2023 | June 30, 2027 | LIU, YUAN | reporter.nih.gov |
| Mechanism and Function of ISG15 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,321,630 | May 1, 2011 | May 31, 2027 | HUIBREGTSE, JON | reporter.nih.gov |
| The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,319,306 | July 14, 2023 | June 30, 2028 | RIVERA, AMARILIZ | reporter.nih.gov |
| Effects of pandemic-related disruption to social connectedness on the brain and emotional wellbeing in adolescents | NIH | National Institute of Mental Health | 2023 to 2025 | $2,299,896 | March 1, 2022 | December 31, 2026 | FAN, CHUN CHIEH | reporter.nih.gov |
| The Evidence Project: Systematic Reviews of Critical HIV Interventions, and Disruption in HIV Services from COVID-19 in LMIC | NIH | National Institute of Mental Health | 2021 to 2025 | $2,292,408 | April 20, 2021 | February 28, 2026 | SWEAT, MICHAEL D | reporter.nih.gov |
| TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,286,496 | September 19, 2022 | July 31, 2027 | RICE, CHARLES M | reporter.nih.gov |
| Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,277,916 | September 20, 2021 | August 31, 2025 | MCINTYRE, THOMAS M | reporter.nih.gov |
| Scaling and Sustaining COVID-19 Vaccination through Meaningful Community Engagement and Care Coordination for Underserved Communities | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,271,972 | September 26, 2022 | June 30, 2027 | STADNICK, NICOLE A | reporter.nih.gov |
| Revising Anti-coronavirus Compounds to Enhance Activity and Optimize Delivery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,268,282 | September 1, 2021 | August 31, 2024 | SCHOOLEY, ROBERT TURNER | reporter.nih.gov |
| Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,263,760 | July 1, 2021 | June 30, 2025 | PERKINS, DOUGLAS JAY | reporter.nih.gov |
| Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19 | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,260,647 | February 15, 2022 | November 30, 2025 | WILSON, MICHAEL R | reporter.nih.gov |
| Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,258,561 | April 1, 2022 | March 31, 2027 | ASCHERIO, ALBERTO | reporter.nih.gov |
| Whole Body Deep Tissue Characterization of the Human Virome | NIH | National Center for Complementary & Integrative Health | 2024 to 2025 | $2,255,898 | September 13, 2024 | August 31, 2029 | HENRICH, TIMOTHY JENSEN | reporter.nih.gov |
| Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,255,725 | May 15, 2023 | April 30, 2028 | TALAAT, ADEL M | reporter.nih.gov |
| DISSECTING MECHANISMS OF INFLAMMATORY SIGNALING ACROSS THE MATERNAL FETAL INTERFACE | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,255,352 | September 15, 2025 | May 31, 2028 | SMITH-ANDERSON, CHRISTIANA ELIZABETH | reporter.nih.gov |
| Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection | NIH | National Institute on Aging | 2021 to 2025 | $2,252,254 | August 15, 2020 | April 30, 2030 | SUN, JIE | reporter.nih.gov |
| LatiNET, a Multilevel Social Network Model to Examine and Address SARS-CoV-2 Misinformation in Low-Income Latinx Communities. | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $2,250,728 | September 20, 2022 | April 1, 2025 | KANAMORI NISHIMURA, MARIANO JUAN | reporter.nih.gov |
| Statistical adjustments of sample representation in community-level estimates of COVID-19 transmission and immunity | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,247,487 | April 1, 2022 | December 31, 2026 | SI, YAJUAN | reporter.nih.gov |
| When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective | NIH | National Institute of Mental Health | 2022 to 2024 | $2,244,785 | September 1, 2022 | July 31, 2027 | BERSHTEYN, ANNA | reporter.nih.gov |
| Emergent Properties of Complex Systems: From Atoms to Macromolecules; from Humans to Societies | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,244,295 | June 1, 2017 | May 31, 2028 | LEVITT, MICHAEL | reporter.nih.gov |
| Initiation of immune responses to SARS COV2 in the oral cavity and upper airway | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2025 | $2,243,785 | November 20, 2023 | March 31, 2027 | GLOVER, SARAH C | reporter.nih.gov |
| Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $2,239,160 | May 10, 2022 | April 1, 2025 | RAMSEY-GOLDMAN, ROSALIND | reporter.nih.gov |
| Trusted Messengers: Supporting Physicians in Promoting COVID-19 Vaccination | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $2,238,005 | May 17, 2021 | February 28, 2025 | FISHER, KIMBERLY | reporter.nih.gov |
| BioGRID: An open resource for biological interactions and network analysis | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $2,235,742 | May 15, 2007 | June 30, 2026 | TYERS, MIKE | reporter.nih.gov |
| Evaluation of Operation Safer Ground: A Community-Level Rapid Housing Intervention for People Vulnerable to COVID-19. | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,231,262 | August 18, 2021 | April 30, 2026 | LORVICK, JENNIFER | reporter.nih.gov |
| Regulation of Host Innate Immunity Against Viral Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,230,417 | April 1, 2010 | May 31, 2026 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Defining the Translocation Mechanisms of SARS-CoV-2 nsp13 Helicase to Aid in Antiviral Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,229,089 | September 17, 2021 | August 31, 2027 | MCCULLAGH, MARTIN | reporter.nih.gov |
| Mechanistic modeling of the innate immune responses of the human lung to understand the inter-individual heterogeneity of COVID-19 pneumonia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,227,734 | July 1, 2023 | June 30, 2027 | MEHRAD, BORNA | reporter.nih.gov |
| Immunological drivers of the transition from epidemicity to endemicity of SARS-CoV-2 in a high transmission LMIC setting | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,222,713 | February 21, 2023 | January 31, 2028 | KO, ALBERT ICKSANG | reporter.nih.gov |
| Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,222,657 | March 1, 2017 | February 28, 2027 | MACK, STEVEN JOHN | reporter.nih.gov |
| Viral and immune kinetics in rhinovirus infection following hematopoietic cell transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,222,417 | June 4, 2020 | May 31, 2025 | WAGHMARE, ALPANA AMALKANT | reporter.nih.gov |
| Deep Learning and Subtyping of Post-COVID-19 Lung Progression Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,221,683 | June 1, 2023 | February 29, 2028 | LIN, CHING-LONG | reporter.nih.gov |
| Role of IRE1 Alpha in Coronavirus Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,221,620 | March 11, 2022 | February 28, 2027 | FINK, SUSAN LEILANI | reporter.nih.gov |
| Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life | NIH | National Institute on Aging | 2023 to 2025 | $2,220,102 | April 1, 2023 | March 31, 2029 | BYERS, AMY LYNN | reporter.nih.gov |
| Research Employing Environmental Systems and Occupational Health Policy Analyses to Interrupt the Impact of Structural Racism on Agricultural Workers and Their Respiratory Health (RESPIRAR) | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $2,219,980 | September 1, 2022 | June 30, 2027 | PAYNE-STURGES, DEVON C | reporter.nih.gov |
| Bridging Disparate Structural/Functional Scales: Multiscale Modeling of Genome Organization and of Viral RNA Frameshifting | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,216,859 | September 1, 2017 | May 31, 2028 | SCHLICK, TAMAR | reporter.nih.gov |
| The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,207,883 | August 4, 2023 | July 31, 2027 | LEAL, SIXTO MANUEL | reporter.nih.gov |
| Mechanisms linking the plasminogen/fibrinogen axis to the pathogenesis of COVID-19 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,206,716 | September 1, 2021 | July 31, 2025 | FLICK, MATTHEW J. | reporter.nih.gov |
| Elucidating the immunology of autoantibody formation and function in COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,205,944 | July 11, 2023 | June 30, 2028 | ROGERS, ANGELA J | reporter.nih.gov |
| Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,205,056 | February 1, 2023 | January 31, 2028 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Coordinated regeneration of lung epithelial and endothelial compartments | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,201,693 | August 20, 2022 | July 31, 2026 | VAUGHAN, ANDREW | reporter.nih.gov |
| Establishment of a Bat Resource for Infectious Disease Research | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,193,256 | September 22, 2023 | August 31, 2028 | SCHOUNTZ, WILLIAM A | reporter.nih.gov |
| COVID-19 Vaccine Effectiveness in Pregnant Women and their Infants | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,181,493 | March 10, 2022 | February 28, 2027 | ZERBO, OUSSENY | reporter.nih.gov |
| AI-based platform for predicting emerging vaccine-escape variants and designing mutation-proof antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,174,184 | May 6, 2022 | April 30, 2027 | WEI, GUOWEI | reporter.nih.gov |
| Acute and Long-Term Impact of SARS-CoV-2 Infection and its Interaction with APOE on Cognitive Function and Neuropathology in Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2022 | $2,172,765 | June 15, 2022 | May 31, 2025 | LI, LING | reporter.nih.gov |
| Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome. | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $2,171,443 | July 1, 2023 | May 31, 2028 | VAKHTIN, ANDREI A | reporter.nih.gov |
| Mechanisms of lung and cardiac pathology in SARS-CoV-2 infections | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,168,424 | April 15, 2023 | January 31, 2027 | YOUNT, JACOB | reporter.nih.gov |
| Role of kynurenic acid in higher cognitive deficits: Mechanism and treatment strategies | NIH | National Institute on Aging | 2023 | $2,168,393 | September 1, 2023 | August 31, 2026 | WANG, MIN | reporter.nih.gov |
| Regulation of inflammatory gene expression during SARS2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,168,339 | February 18, 2022 | January 31, 2027 | MARAZZI, IVAN | reporter.nih.gov |
| Natural model for evaluating within- and cross-species virus transmission | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,167,077 | July 1, 2023 | June 30, 2028 | LANGLOIS, RYAN | reporter.nih.gov |
| Marshallese: Alternate Surveillance for COVID-19 in a Unique Population | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $2,164,912 | December 21, 2020 | May 31, 2025 | DILLARD, DENISE A | reporter.nih.gov |
| Impact of the COVID-19 Pandemic on Safety Net Performance, Disparities, and Vulnerable Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,160,105 | September 15, 2022 | May 31, 2027 | EVANS CUELLAR, ALISON | reporter.nih.gov |
| Prenatal Social Connection and Disruption During the COVID-19 Pandemic: Effects on Maternal and Infant Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,157,210 | June 1, 2021 | January 31, 2027 | SAXBE, DARBY E. | reporter.nih.gov |
| Community-Academic Partnerships to Address COVID-19 Inequities within African American Communities | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,156,802 | September 19, 2021 | August 31, 2026 | RITCHWOOD, TIARNEY D | reporter.nih.gov |
| Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,156,579 | March 1, 2023 | February 29, 2028 | MARKOVITZ, DAVID MICHAEL | reporter.nih.gov |
| Immune, hormonal, and muscle mitochondrial determinants of recovery in Acute Respiratory Distress Syndrome survivors | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,151,841 | September 1, 2023 | July 31, 2028 | BALDWIN, MATTHEW R | reporter.nih.gov |
| CD2H - National COVID Cohort Collaborative (N3C) | NIH | National Center for Advancing Translational Sciences | 2021 | $2,148,955 | March 15, 2021 | June 30, 2021 | HAENDEL, MELISSA A | reporter.nih.gov |
| Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,140,211 | June 1, 2023 | May 31, 2028 | SIGAL, LUIS J | reporter.nih.gov |
| Pediatric Chronic Headache and COVID-19: Use of Machine Learning and Biobehavioral Analysis to Classify Headache Mechanism and Optimize Treatment Course. | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,140,031 | August 18, 2022 | May 31, 2027 | HOLMES, SCOTT | reporter.nih.gov |
| Assessing the Impact of SARS-CoV-2 on Adipose Tissue Function and Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,139,449 | May 1, 2023 | April 30, 2028 | LO, JAMES C | reporter.nih.gov |
| Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,131,407 | June 17, 2022 | May 31, 2027 | GOULDER, PHILIP J | reporter.nih.gov |
| Reducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart Technology | NIH | National Institute on Aging | 2021 to 2023 | $2,129,618 | September 30, 2021 | February 28, 2025 | WOLPERT, RACHEL MARIE | reporter.nih.gov |
| Unequal Parenthoods: Population Perspectives on Gender, Race, and Sexual Minority Disparities in Family Stress and Health During Crises | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,123,412 | September 21, 2021 | August 31, 2026 | KAMP DUSH, CLAIRE M | reporter.nih.gov |
| The Evolutionary Basis of the Developmental Course and Etiologies of Anxiety and Disruptive Behaviors during Early Adolescence | NIH | National Institute of Mental Health | 2023 to 2025 | $2,122,198 | August 17, 2023 | May 31, 2028 | NOMURA, YOKO | reporter.nih.gov |
| Linking SARS-CoV-2 Aerosol Viability and Environmental Factors in Healthcare Settings | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,121,919 | August 17, 2023 | July 31, 2027 | KELLY, KERRY | reporter.nih.gov |
| Influenza & COVID Obstetric and Perinatal Epidemiology Study in India | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,121,321 | September 23, 2022 | August 31, 2027 | HIBBERD, PATRICIA L | reporter.nih.gov |
| mRNA-encoded Cas13 as a pan-respiratory antiviral | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,120,971 | January 23, 2023 | December 31, 2027 | SANTANGELO, PHILIP J | reporter.nih.gov |
| Effect of post-acute care pay for performance in skilled nursing facilities on outcomes and disparities | NIH | National Institute on Aging | 2022 to 2025 | $2,116,949 | March 1, 2022 | November 30, 2026 | BURKE, ROBERT EDWARD | reporter.nih.gov |
| The effects of the pandemic on formal and informal care among adults with dementia | NIH | National Institute on Aging | 2022 to 2025 | $2,110,571 | September 15, 2022 | May 31, 2027 | CHOI, HWAJUNG | reporter.nih.gov |
| Risk and resilience: Evaluating the multigenerational effect of a psychosocial maternal depression intervention against COVID-19-related stressors | NIH | National Institute of Mental Health | 2022 | $2,106,882 | September 20, 2022 | September 19, 2025 | MASELKO, JOANNA | reporter.nih.gov |
| The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 replication and Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,103,613 | September 21, 2021 | August 31, 2026 | RAJSBAUM, RICARDO | reporter.nih.gov |
| Multilevel Determinants of Racial and Ethnic Disparities in Maternal Morbidity and Mortality in the Context of COVID-19 Pandemic | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $2,102,090 | September 7, 2021 | November 30, 2023 | LI, XIAOMING | reporter.nih.gov |
| The crossroads between the methionine cycle and the coronavirus RNA capping. | NIH | National Institute of General Medical Sciences | 2025 | $2,094,250 | September 1, 2025 | August 31, 2029 | ROSAS LEMUS, MONICA | reporter.nih.gov |
| The impacts of HIV-related service interruptions during COVID-19 pandemic in South Carolina | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,093,698 | May 4, 2023 | April 30, 2028 | QIAO, SHAN | reporter.nih.gov |
| Cellular Mechanism of Oxysterol-Binding Protein (OSBP) in Viral Proliferation: A Chemical Biology Approach | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,088,096 | April 8, 2021 | March 31, 2027 | BURGETT, ANTHONY W.G. | reporter.nih.gov |
| The effects of pandemic-related stressors on change in CVD Risk: The protective role of universal prevention | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,086,038 | May 2, 2023 | April 30, 2027 | GRAHAM-ENGELAND, JENNIFER ELISE | reporter.nih.gov |
| Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,083,062 | February 1, 2023 | January 31, 2028 | TEAGUE, WILLIAM GERALD | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Research Triangle Institute | Research Triangle Park, NC | 5 | $970.4 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 22 | $700.1 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 8 | $270.5 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 36 | $254.1 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 40 | $207.5 million | 0 | $0 |
| Duke University | Durham, NC | 30 | $168.2 million | 0 | $0 |
| Technical Resources International, Inc. | Bethesda, MD | 2 | $150.1 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 1 | $89.8 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 39 | $88.1 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 14 | $83 million | 0 | $0 |
| Emory University | Atlanta, GA | 33 | $81.6 million | 0 | $0 |
| Axle Informatics, LLC | North Bethesda, MD | 8 | $78 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 41 | $76.6 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 53 | $73.8 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 41 | $70.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 32 | $67.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 31 | $58.4 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 14 | $52.9 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 41 | $51.1 million | 0 | $0 |
| Washington University | Saint Louis, MO | 27 | $48.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 30 | $43.7 million | 0 | $0 |
| Yale University | New Haven, CT | 35 | $40.4 million | 0 | $0 |
| Palantir Technologies, Inc. | Denver, CO | 3 | $40 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 25 | $39.7 million | 0 | $0 |
| University of Chicago | Chicago, IL | 9 | $38.6 million | 0 | $0 |
| National Collegiate Inventors and Innovators Alliance | Hadley, MA | 5 | $38.5 million | 0 | $0 |
| University of Washington | Seattle, WA | 33 | $36.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 12 | $36.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 18 | $36.1 million | 0 | $0 |
| University of New Mexico Health Scis CTR | Albuquerque, NM | 7 | $35.9 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 12 | $33.9 million | 0 | $0 |
| West Virginia University Research Corporation | Morgantown, WV | 2 | $32.3 million | 0 | $0 |
| National Jewish Health | Denver, CO | 2 | $30 million | 0 | $0 |
| La Jolla Institute for Immunology | La Jolla, CA | 5 | $29.3 million | 0 | $0 |
| Montana State University | Bozeman, MT | 4 | $29.1 million | 0 | $0 |
| Luminostics, Inc. | San Jose, CA | 1 | $28.6 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 15 | $28.2 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 18 | $27.8 million | 0 | $0 |
| Mainehealth | Portland, ME | 1 | $27.4 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 3 | $27.2 million | 0 | $0 |
| Rockefeller University | New York, NY | 10 | $27 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 22 | $26.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 25 | $25.9 million | 0 | $0 |
| LSU Pennington Biomedical Research CTR | Baton Rouge, LA | 1 | $25.5 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 15 | $24.3 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 14 | $23.1 million | 0 | $0 |
| Brown University | Providence, RI | 13 | $22.8 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 7 | $22.7 million | 0 | $0 |
| University of Louisville | Louisville, KY | 6 | $22 million | 0 | $0 |
| Ohio State University | Columbus, OH | 21 | $21.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 8 | $20.9 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 6 | $20.8 million | 0 | $0 |
| New Mexico State University | Las Cruces, NM | 1 | $20.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 15 | $20.1 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 12 | $20.1 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 6 | $19.5 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 17 | $18.9 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 8 | $18.6 million | 0 | $0 |
| University of Texas Med BR Galveston | Galveston, TX | 13 | $18.4 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 9 | $18 million | 0 | $0 |
| Colorado State University | Fort Collins, CO | 8 | $17.9 million | 0 | $0 |
| Universitat Bern | Bern | 1 | $16.8 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 10 | $16.2 million | 0 | $0 |
| University of Houston | Houston, TX | 2 | $15.7 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 10 | $15.6 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 14 | $15.4 million | 0 | $0 |
| Arkansas Children's Hospital Res Inst | Little Rock, AR | 2 | $15.4 million | 0 | $0 |
| Feinstein Institute for Medical Research | Manhasset, NY | 1 | $15 million | 0 | $0 |
| Foundation for the Nih | North Bethesda, MD | 2 | $14.9 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 8 | $14.5 million | 0 | $0 |
| University of Puerto Rico Med Sciences | San Juan, PR | 1 | $14.1 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 10 | $13.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 12 | $13.8 million | 0 | $0 |
| Louisiana State Univ HSC Shreveport | Shreveport, LA | 4 | $13.4 million | 0 | $0 |
| Steelworker Charitable/educational Org | Pittsburgh, PA | 1 | $13.4 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 2 | $13.2 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 13 | $13 million | 0 | $0 |
| T3D Therapeutics, Inc. | Research Triangle Park, NC | 1 | $12.6 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 14 | $12.6 million | 0 | $0 |
| Baruch S. Blumberg Institute | Doylestown, PA | 1 | $12.5 million | 0 | $0 |
| Helix | San Carlos, CA | 1 | $12.5 million | 0 | $0 |
| Washington State University | Pullman, WA | 8 | $12.4 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 8 | $12.1 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 21 | $11.9 million | 0 | $0 |
| University of Florida | Gainesville, FL | 14 | $11.8 million | 0 | $0 |
| Regenstrief Institute, Inc. | Indianapolis, IN | 4 | $11.6 million | 0 | $0 |
| Aligos Therapeutics, Inc. | South San Francisco, CA | 1 | $11.3 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 10 | $11.3 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 14 | $11.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 10 | $11.2 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 10 | $10.6 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 7 | $10.4 million | 0 | $0 |
| New York University | New York, NY | 5 | $10.4 million | 0 | $0 |
| National Bureau of Economic Research Inc | Cambridge, MA | 3 | $10.3 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 7 | $10.3 million | 0 | $0 |
| Rand Corporation | Santa Monica, CA | 7 | $10 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 10 | $9.9 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 4 | $9.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 8 | $9.8 million | 0 | $0 |
| LSU Health Sciences Center | New Orleans, LA | 4 | $9.8 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 733 | $567,671,706 | 0 | $0 |
| 2024 | 868 | $1,107,661,367 | 0 | $0 |
| 2023 | 987 | $1,385,170,306 | 0 | $0 |
| 2022 | 975 | $1,134,202,624 | 0 | $0 |
| 2021 | 883 | $1,869,513,015 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 8 awards here | |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 4 awards here | |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) | PA-24-184 | NIH | May 8, 2027 | Not listed | Notice number printed on 1 award here | |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 744 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 744 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 744 awards here |
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.